THOMAS WALSH

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Disorders

Living Beings

Procedures

Microbial Sensitivity Tests

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Roilides E; Zaoutis T E; Walsh T J
Invasive zygomycosis in neonates and children.
Pfaller M A; Diekema D J; Ghannoum M A; Rex J H; Alexander B D; Andes D; Brown S D; Chaturvedi V; Espinel-Ingroff A; Fowler C L; Johnson E M; Knapp C C; Motyl M R; Ostrosky-Zeichner L; Sheehan D J; Walsh T J;
Wild-type MIC distribution and epidemiological cutoff values for Aspergillus fumigatus and three triazoles as determined by the Clinical and Laboratory Standards Institute broth microdilution methods.
Spellberg Brad; Walsh Thomas J; Kontoyiannis Dimitrios P; Edwards John; Ibrahim Ashraf S
Recent advances in the management of mucormycosis: from bench to bedside.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of THOMAS WALSH (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Roilides E; Zaoutis T E; Walsh T J
Invasive zygomycosis in neonates and children.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2009;15 Suppl 5():50-4.
2009: Pfaller M A; Diekema D J; Ghannoum M A; Rex J H; Alexander B D; Andes D; Brown S D; Chaturvedi V; Espinel-Ingroff A; Fowler C L; Johnson E M; Knapp C C; Motyl M R; Ostrosky-Zeichner L; Sheehan D J; Walsh T J;
Wild-type MIC distribution and epidemiological cutoff values for Aspergillus fumigatus and three triazoles as determined by the Clinical and Laboratory Standards Institute broth microdilution methods.
Journal of clinical microbiology 2009;47(10):3142-6.
2009: Spellberg Brad; Walsh Thomas J; Kontoyiannis Dimitrios P; Edwards John; Ibrahim Ashraf S
Recent advances in the management of mucormycosis: from bench to bedside.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;48(12):1743-51.
2009: Petraitis Vidmantas; Petraitiene Ruta; Hope William W; Meletiadis Joseph; Mickiene Diana; Hughes Johanna E; Cotton Margaret P; Stergiopoulou Theodouli; Kasai Miki; Francesconi Andrea; Schaufele Robert L; Sein Tin; Avila Nilo A; Bacher John; Walsh Thomas J
Combination therapy in treatment of experimental pulmonary aspergillosis: in vitro and in vivo correlations of the concentration- and dose- dependent interactions between anidulafungin and voriconazole by Bliss independence drug interaction analysis.
Antimicrobial agents and chemotherapy 2009;53(6):2382-91.
2009: Roilides Emmanuel; Simitsopoulou Maria; Katragkou Aspasia; Walsh Thomas J
Host immune response against Scedosporium species.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2009;47(4):433-40.
2009: Smith P Brian; Walsh Thomas J; Hope William; Arrieta Antonio; Takada Akitsugu; Kovanda Laura L; Kearns Gregory L; Kaufman David; Sawamoto Taiji; Buell Donald N; Benjamin Daniel K
Pharmacokinetics of an elevated dosage of micafungin in premature neonates.
The Pediatric infectious disease journal 2009;28(5):412-5.
2009: Moriyama Brad; Elinoff Jason; Danner Robert L; Gea-Banacloche Juan; Pennick Gennethel; Rinaldi Michael G; Walsh Thomas J
Accelerated metabolism of voriconazole and its partial reversal by cimetidine.
Antimicrobial agents and chemotherapy 2009;53(4):1712-4.
2009: Shoham Shmuel; Han Grace; Granek Tal; Walsh Thomas; Magee Michelle F
Association between blood glucose levels and development of candidemia in hospitalized patients.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2009;15(2):111-5.
2009: Pappas Peter G; Kauffman Carol A; Andes David; Benjamin Daniel K; Calandra Thierry F; Edwards John E; Filler Scott G; Fisher John F; Kullberg Bart-Jan; Ostrosky-Zeichner Luis; Reboli Annette C; Rex John H; Walsh Thomas J; Sobel Jack D;
Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;48(5):503-35.
2009: Stergiopoulou Theodouli; Meletiadis Joseph; Sein Tin; Papaioannidou Paraskevi; Tsiouris Ioannis; Roilides Emmanuel; Walsh Thomas J
Comparative pharmacodynamic interaction analysis between ciprofloxacin, moxifloxacin and levofloxacin and antifungal agents against Candida albicans and Aspergillus fumigatus.
The Journal of antimicrobial chemotherapy 2009;63(2):343-8.
2009: Estes Kristina E; Penzak Scott R; Calis Karim Anton; Walsh Thomas J
Pharmacology and antifungal properties of anidulafungin, a new echinocandin.
Pharmacotherapy 2009;29(1):17-30.
2008: Prasad Priya A; Coffin Susan E; Leckerman Kateri H; Walsh Thomas J; Zaoutis Theoklis E
Pediatric antifungal utilization: new drugs, new trends.
The Pediatric infectious disease journal 2008;27(12):1083-8.
2008: Shoham S; Pic-Aluas L; Taylor J; Cortez K; Rinaldi M G; Shea Y; Walsh T J
Transplant-associated Ochroconis gallopava infections.
Transplant infectious disease : an official journal of the Transplantation Society 2008;10(6):442-8.
2008: Stergiopoulou Theodouli; De Lucca Anthony J; Meletiadis Joseph; Sein Tin; Boue Stephen M; Schaufele Robert; Roilides Emmanuel; Ghannoum Mahmoud; Walsh Thomas J
In vitro activity of CAY-1, a saponin from Capsicum frutescens, against Microsporum and Trichophyton species.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2008;46(8):805-10.
2008: Kasai Miki; Harrington Susan M; Francesconi Andrea; Petraitis Vidmantas; Petraitiene Ruta; Beveridge Mara G; Knudsen Tena; Milanovich Jeffery; Cotton Margaret P; Hughes Johanna; Schaufele Robert L; Sein Tin; Bacher John; Murray Patrick R; Kontoyiannis Dimitrios P; Walsh Thomas J
Detection of a molecular biomarker for zygomycetes by quantitative PCR assays of plasma, bronchoalveolar lavage, and lung tissue in a rabbit model of experimental pulmonary zygomycosis.
Journal of clinical microbiology 2008;46(11):3690-702.
2008: Ostrosky-Zeichner Luis; Rex John H; Pfaller Michael A; Diekema Daniel J; Alexander Barbara D; Andes David; Brown Steven D; Chaturvedi Vishnu; Ghannoum Mahmoud A; Knapp Cindy C; Sheehan Daniel J; Walsh Thomas J
Rationale for reading fluconazole MICs at 24 hours rather than 48 hours when testing Candida spp. by the CLSI M27-A2 standard method.
Antimicrobial agents and chemotherapy 2008;52(11):4175-7.
2008: Petraitiene Ruta; Petraitis Vidmantas; Hope William W; Mickiene Diana; Kelaher Amy M; Murray Heidi A; Mya-San Christine; Hughes Johanna E; Cotton Margaret P; Bacher John; Walsh Thomas J
Cerebrospinal fluid and plasma (1-->3)-beta-D-glucan as surrogate markers for detection and monitoring of therapeutic response in experimental hematogenous Candida meningoencephalitis.
Antimicrobial agents and chemotherapy 2008;52(11):4121-9.
2008: Hayden Randall; Pounds Stanley; Knapp Katherine; Petraitiene Ruta; Schaufele Robert L; Sein Tin; Walsh Thomas J
Galactomannan antigenemia in pediatric oncology patients with invasive aspergillosis.
The Pediatric infectious disease journal 2008;27(9):815-9.
2008: Segal Brahm H; Herbrecht Raoul; Stevens David A; Ostrosky-Zeichner Luis; Sobel Jack; Viscoli Claudio; Walsh Thomas J; Maertens Johan; Patterson Thomas F; Perfect John R; Dupont Bertrand; Wingard John R; Calandra Thierry; Kauffman Carol A; Graybill John R; Baden Lindsey R; Pappas Peter G; Bennett John E; Kontoyiannis Dimitrios P; Cordonnier Catherine; Viviani Maria Anna; Bille Jacques; Almyroudis Nikolaos G; Wheat L Joseph; Graninger Wolfgang; Bow Eric J; Holland Steven M; Kullberg Bart-Jan; Dismukes William E; De Pauw Ben E
Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;47(5):674-83.
2008: Simitsopoulou Maria; Roilides Emmanuel; Paliogianni Fotini; Likartsis Christodoulos; Ioannidis John; Kanellou Kalliopi; Walsh Thomas J
Immunomodulatory effects of voriconazole on monocytes challenged with Aspergillus fumigatus: differential role of Toll-like receptors.
Antimicrobial agents and chemotherapy 2008;52(9):3301-6.
2008: Smith P Brian; Garges Harmony P; Cotton C Michael; Walsh Thomas J; Clark Reese H; Benjamin Daniel K
Meningitis in preterm neonates: importance of cerebrospinal fluid parameters.
American journal of perinatology 2008;25(7):421-6.
2008: Pfaller M A; Diekema D J; Ostrosky-Zeichner L; Rex J H; Alexander B D; Andes D; Brown S D; Chaturvedi V; Ghannoum M A; Knapp C C; Sheehan D J; Walsh T J
Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: analysis and proposal for interpretive MIC breakpoints.
Journal of clinical microbiology 2008;46(8):2620-9.
2008: Lamaris Gregory A; Lewis Russell E; Chamilos Georgios; May Gregory S; Safdar Amar; Walsh Thomas J; Raad Issam I; Kontoyiannis Dimitrios P
Caspofungin-mediated beta-glucan unmasking and enhancement of human polymorphonuclear neutrophil activity against Aspergillus and non-Aspergillus hyphae.
The Journal of infectious diseases 2008;198(2):186-92.
2008: De Pauw Ben; Walsh Thomas J; Donnelly J Peter; Stevens David A; Edwards John E; Calandra Thierry; Pappas Peter G; Maertens Johan; Lortholary Olivier; Kauffman Carol A; Denning David W; Patterson Thomas F; Maschmeyer Georg; Bille Jacques; Dismukes William E; Herbrecht Raoul; Hope William W; Kibbler Christopher C; Kullberg Bart Jan; Marr Kieren A; Muñoz Patricia; Odds Frank C; Perfect John R; Restrepo Angela; Ruhnke Markus; Segal Brahm H; Sobel Jack D; Sorrell Tania C; Viscoli Claudio; Wingard John R; Zaoutis Theoklis; Bennett John E;
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;46(12):1813-21.
2008: Francesconi Andrea; Kasai Miki; Harrington Susan M; Beveridge Mara G; Petraitiene Ruta; Petraitis Vidmantas; Schaufele Robert L; Walsh Thomas J
Automated and manual methods of DNA extraction for Aspergillus fumigatus and Rhizopus oryzae analyzed by quantitative real-time PCR.
Journal of clinical microbiology 2008;46(6):1978-84.
2008: Stergiopoulou Theodouli; Meletiadis Joseph; Sein Tin; Papaioannidou Paraskevi; Tsiouris Ioannis; Roilides Emmanuel; Walsh Thomas J
Isobolographic analysis of pharmacodynamic interactions between antifungal agents and ciprofloxacin against Candida albicans and Aspergillus fumigatus.
Antimicrobial agents and chemotherapy 2008;52(6):2196-204.
2008: Meletiadis Joseph; Chanock Stephen; Walsh Thomas J
Defining targets for investigating the pharmacogenomics of adverse drug reactions to antifungal agents.
Pharmacogenomics 2008;9(5):561-84.
2008: Pyrgos Vasilios; Shoham Shmuel; Walsh Thomas J
Pulmonary zygomycosis.
Seminars in respiratory and critical care medicine 2008;29(2):111-20.
2008: Dotis John; Simitsopoulou Maria; Dalakiouridou Maria; Konstantinou Thomai; Panteliadis Christos; Walsh Thomas J; Roilides Emmanuel
Amphotericin B formulations variably enhance antifungal activity of human neutrophils and monocytes against Fusarium solani: comparison with Aspergillus fumigatus.
The Journal of antimicrobial chemotherapy 2008;61(4):810-7.
2008: Chaturvedi Vishnu; Ramani Rama; Ghannoum Mahmoud A; Killian Scott B; Holliday Nicole; Knapp Cindy; Ostrosky-Zeichner Luis; Messer Shawn A; Pfaller Michael A; Iqbal Naureen J; Arthington-Skaggs Beth A; Vazquez Jose A; Sein Tin; Rex John H; Walsh Thomas J
Multilaboratory testing of antifungal combinations against a quality control isolate of Candida krusei.
Antimicrobial agents and chemotherapy 2008;52(4):1500-2.
2008: Wheat L J; Walsh T J
Diagnosis of invasive aspergillosis by galactomannan antigenemia detection using an enzyme immunoassay.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2008;27(4):245-51.
2008: Rau Rachel; Fitzhugh Courtney D; Baird Kristin; Cortez Karroll J; Li Li; Fischer Steven H; Cowen Edward W; Balow James E; Walsh Thomas J; Cohen Jeffrey I; Wayne Alan S
Triad of severe abdominal pain, inappropriate antidiuretic hormone secretion, and disseminated varicella-zoster virus infection preceding cutaneous manifestations after hematopoietic stem cell transplantation: utility of PCR for early recognition and therapy.
The Pediatric infectious disease journal 2008;27(3):265-8.
2008: Marsh Rebecca A; Lucky Anne W; Walsh Thomas J; Pacheco M Cristina; Rinaldi Michael G; Mailler-Savage Erica; Puel Anne; Casanova Jean-Laurent; Bleesing Jack J; Filippi Marie-Dominique; Williams David A; Daines Michael O; Filipovich Alexandra H
Cutaneous infection with Metarhizium anisopliae in a patient with hypohidrotic ectodermal dysplasia and immune deficiency.
The Pediatric infectious disease journal 2008;27(3):283-4.
2008: Simitsopoulou Maria; Roilides Emmanuel; Maloukou Avgi; Gil-Lamaignere Cristina; Walsh Thomas J
Interaction of amphotericin B lipid formulations and triazoles with human polymorphonuclear leucocytes for antifungal activity against Zygomycetes.
Mycoses 2008;51(2):147-54.
2008: Walsh Thomas J; Anaissie Elias J; Denning David W; Herbrecht Raoul; Kontoyiannis Dimitrios P; Marr Kieren A; Morrison Vicki A; Segal Brahm H; Steinbach William J; Stevens David A; van Burik Jo-Anne; Wingard John R; Patterson Thomas F;
Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;46(3):327-60.
2008: Chamilos G; Lewis R E; Lamaris G; Walsh T J; Kontoyiannis D P
Zygomycetes hyphae trigger an early, robust proinflammatory response in human polymorphonuclear neutrophils through toll-like receptor 2 induction but display relative resistance to oxidative damage.
Antimicrobial agents and chemotherapy 2008;52(2):722-4.
2008: Cortez Karoll J; Roilides Emmanuel; Quiroz-Telles Flavio; Meletiadis Joseph; Antachopoulos Charalampos; Knudsen Tena; Buchanan Wendy; Milanovich Jeffrey; Sutton Deanna A; Fothergill Annette; Rinaldi Michael G; Shea Yvonne R; Zaoutis Theoklis; Kottilil Shyam; Walsh Thomas J
Infections caused by Scedosporium spp.
Clinical microbiology reviews 2008;21(1):157-97.
2008: Hope William W; Mickiene Diana; Petraitis Vidmantas; Petraitiene Ruta; Kelaher Amy M; Hughes Joanna E; Cotton Margaret P; Bacher John; Keirns James J; Buell Donald; Heresi Gloria; Benjamin Daniel K; Groll Andreas H; Drusano George L; Walsh Thomas J
The pharmacokinetics and pharmacodynamics of micafungin in experimental hematogenous Candida meningoencephalitis: implications for echinocandin therapy in neonates.
The Journal of infectious diseases 2008;197(1):163-71.
2008: Antachopoulos Charalampos; Meletiadis Joseph; Sein Tin; Roilides Emmanuel; Walsh Thomas J
Comparative in vitro pharmacodynamics of caspofungin, micafungin, and anidulafungin against germinated and nongerminated Aspergillus conidia.
Antimicrobial agents and chemotherapy 2008;52(1):321-8.
2008: Lane Jason W; Rehak Nadja N; Hortin Glen L; Zaoutis Theoklis; Krause Philip R; Walsh Thomas J
Pseudohyperphosphatemia associated with high-dose liposomal amphotericin B therapy.
Clinica chimica acta; international journal of clinical chemistry 2008;387(1-2):145-9.
2007: Zaoutis Theoklis; Walsh Thomas J
Antifungal therapy for neonatal candidiasis.
Current opinion in infectious diseases 2007;20(6):592-7.
2007: Antachopoulos Charalampos; Walsh Thomas J; Roilides Emmanuel
Fungal infections in primary immunodeficiencies.
European journal of pediatrics 2007;166(11):1099-117.
2007: Chiou Christine C; Walsh Thomas J; Groll Andreas H
Clinical pharmacology of antifungal agents in pediatric patients.
Expert opinion on pharmacotherapy 2007;8(15):2465-89.
2007: Hope William W; Warn Peter A; Sharp Andrew; Reed Paul; Keevil Brian; Louie Arnold; Walsh Thomas J; Denning David W; Drusano George L
Optimization of the dosage of flucytosine in combination with amphotericin B for disseminated candidiasis: a pharmacodynamic rationale for reduced dosing.
Antimicrobial agents and chemotherapy 2007;51(10):3760-2.
2007: Hope William W; Seibel Nita L; Schwartz Cindy L; Arrieta Antonio; Flynn Patricia; Shad Aziza; Albano Edythe; Keirns James J; Buell Donald N; Gumbo Tawanda; Drusano George L; Walsh Thomas J
Population pharmacokinetics of micafungin in pediatric patients and implications for antifungal dosing.
Antimicrobial agents and chemotherapy 2007;51(10):3714-9.
2007: Meletiadis Joseph; Walsh Thomas J; Choi Eun Hwa; Pappas Peter G; Ennis David; Douglas Jeffrey; Pankey George A; Larsen Robert A; Hamill Richard J; Chanock Stephen
Study of common functional genetic polymorphisms of FCGR2A, 3A and 3B genes and the risk for cryptococcosis in HIV-uninfected patients.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2007;45(6):513-8.
2007: Cummings Jessica R; Jamison Ginger R; Boudreaux Jan W; Howles Merry J; Walsh Thomas J; Hayden Randall T
Cross-reactivity of non-Aspergillus fungal species in the Aspergillus galactomannan enzyme immunoassay.
Diagnostic microbiology and infectious disease 2007;59(1):113-5.
2007: Meletiadis Joseph; Antachopoulos Charalampos; Stergiopoulou Theodouli; Pournaras Spyros; Roilides Emmanuel; Walsh Thomas J
Differential fungicidal activities of amphotericin B and voriconazole against Aspergillus species determined by microbroth methodology.
Antimicrobial agents and chemotherapy 2007;51(9):3329-37.
2007: Kontny Udo; Walsh Thomas J; Rossler Jochen; Uhl Markus; Niemeyer Charlotte M
Successful treatment of refractory chronic disseminated candidiasis after prolonged administration of caspofungin in a child with acute myeloid leukemia.
Pediatric blood & cancer 2007;49(3):360-2.
2007: Zaoutis Theoklis E; Roilides Emmanuel; Chiou Christine C; Buchanan Wendy L; Knudsen Tena A; Sarkisova Tatyana A; Schaufele Robert L; Sein Michael; Sein Tin; Prasad Priya A; Chu Jaclyn H; Walsh Thomas J
Zygomycosis in children: a systematic review and analysis of reported cases.
The Pediatric infectious disease journal 2007;26(8):723-7.
2007: Espinel-Ingroff A; Fothergill A; Ghannoum M; Manavathu E; Ostrosky-Zeichner L; Pfaller M A; Rinaldi M G; Schell W; Walsh T J
Quality control and reference guidelines for CLSI broth microdilution method (M38-A document) for susceptibility testing of anidulafungin against molds.
Journal of clinical microbiology 2007;45(7):2180-2.
2007: Reboli Annette C; Rotstein Coleman; Pappas Peter G; Chapman Stanley W; Kett Daniel H; Kumar Deepali; Betts Robert; Wible Michele; Goldstein Beth P; Schranz Jennifer; Krause David S; Walsh Thomas J;
Anidulafungin versus fluconazole for invasive candidiasis.
The New England journal of medicine 2007;356(24):2472-82.
2007: Meletiadis Joseph; Stergiopoulou Theodouli; O'Shaughnessy Elizabeth M; Peter Joanne; Walsh Thomas J
Concentration-dependent synergy and antagonism within a triple antifungal drug combination against Aspergillus species: analysis by a new response surface model.
Antimicrobial agents and chemotherapy 2007;51(6):2053-64.
2007: Zaoutis Theoklis E; Heydon Kateri; Localio Russell; Walsh Thomas J; Feudtner Chris
Outcomes attributable to neonatal candidiasis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;44(9):1187-93.
2007: De Jesus Magdia; Hackett Emily; Durkin Michelle; Connolly Patricia; Casadevall Arturo; Petraitiene Ruta; Walsh Thomas J; Wheat L Joseph
Galactoxylomannan does not exhibit cross-reactivity in the platelia Aspergillus enzyme immunoassay.
Clinical and vaccine immunology : CVI 2007;14(5):624-7.
2007: Wheat L Joseph; Hackett Emily; Durkin Michelle; Connolly Patricia; Petraitiene Ruta; Walsh Thomas J; Knox Kenneth; Hage Chadi
Histoplasmosis-associated cross-reactivity in the BioRad Platelia Aspergillus enzyme immunoassay.
Clinical and vaccine immunology : CVI 2007;14(5):638-40.
2007: Hope William W; Shoham Shmuel; Walsh Thomas J
The pharmacology and clinical use of caspofungin.
Expert opinion on drug metabolism & toxicology 2007;3(2):263-74.
2007: Santos Roberto P; Sánchez Pablo J; Mejias Asuncion; Benjamin Daniel K; Walsh Thomas J; Patel Sanjay; Jafri Hasan S
Successful medical treatment of cutaneous aspergillosis in a premature infant using liposomal amphotericin B, voriconazole and micafungin.
The Pediatric infectious disease journal 2007;26(4):364-6.
2007: Stergiopoulou Theodouli; Meletiadis Joseph; Roilides Emmanuel; Kleiner David E; Schaufele R; Roden Maureen; Harrington Susan; Dad Luqman; Segal Brahm; Walsh Thomas J
Host-dependent patterns of tissue injury in invasive pulmonary aspergillosis.
American journal of clinical pathology 2007;127(3):349-55.
2007: Simitsopoulou M; Roilides E; Likartsis C; Ioannidis J; Orfanou A; Paliogianni F; Walsh T J
Expression of immunomodulatory genes in human monocytes induced by voriconazole in the presence of Aspergillus fumigatus.
Antimicrobial agents and chemotherapy 2007;51(3):1048-54.
2007: Antachopoulos Charalampos; Meletiadis Joseph; Sein Tin; Roilides Emmanuel; Walsh Thomas J
Concentration-dependent effects of caspofungin on the metabolic activity of Aspergillus species.
Antimicrobial agents and chemotherapy 2007;51(3):881-7.
2007: Smith P B; Steinbach W J; Cotten C M; Schell W A; Perfect J R; Walsh T J; Benjamin D K
Caspofungin for the treatment of azole resistant candidemia in a premature infant.
Journal of perinatology : official journal of the California Perinatal Association 2007;27(2):127-9.
2007: Hope William W; Kruhlak Michael J; Lyman Caron A; Petraitiene Ruta; Petraitis Vidmantas; Francesconi Andrea; Kasai Miki; Mickiene Diana; Sein Tin; Peter Joanne; Kelaher Amy M; Hughes Johanna E; Cotton Margaret P; Cotten Catherine J; Bacher John; Tripathi Sanjay; Bermudez Louis; Maugel Timothy K; Zerfas Patricia M; Wingard John R; Drusano George L; Walsh Thomas J
Pathogenesis of Aspergillus fumigatus and the kinetics of galactomannan in an in vitro model of early invasive pulmonary aspergillosis: implications for antifungal therapy.
The Journal of infectious diseases 2007;195(3):455-66.
2007: Segal Brahm H; Almyroudis Nikolaos G; Battiwalla Minoo; Herbrecht Raoul; Perfect John R; Walsh Thomas J; Wingard John R
Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;44(3):402-9.
2007: Antachopoulos Charalampos; Meletiadis Joseph; Sein Tin; Roilides Emmanuel; Walsh Thomas J
Use of high inoculum for early metabolic signalling and rapid susceptibility testing of Aspergillus species.
The Journal of antimicrobial chemotherapy 2007;59(2):230-7.
2007: Cohen-Wolkowiez M; Smith P B; Mangum B; Steinbach W J; Alexander B D; Cotten C M; Clark R H; Walsh T J; Benjamin D K
Neonatal Candida meningitis: significance of cerebrospinal fluid parameters and blood cultures.
Journal of perinatology : official journal of the California Perinatal Association 2007;27(2):97-100.
2007: Cornely Oliver A; Maertens Johan; Winston Drew J; Perfect John; Ullmann Andrew J; Walsh Thomas J; Helfgott David; Holowiecki Jerzy; Stockelberg Dick; Goh Yeow-Tee; Petrini Mario; Hardalo Cathy; Suresh Ramachandran; Angulo-Gonzalez David
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.
The New England journal of medicine 2007;356(4):348-59.
2007: Verdaguer Virginia; Walsh Thomas J; Hope William; Cortez Karoll J
Galactomannan antigen detection in the diagnosis of invasive aspergillosis.
Expert review of molecular diagnostics 2007;7(1):21-32.
2007: Walsh Thomas J; Raad Issam; Patterson Thomas F; Chandrasekar Pranatharthi; Donowitz Gerald R; Graybill Richard; Greene Reginald E; Hachem Ray; Hadley Susan; Herbrecht Raoul; Langston Amelia; Louie Arnold; Ribaud Patricia; Segal Brahm H; Stevens David A; van Burik Jo-Anne H; White Charles S; Corcoran Gavin; Gogate Jagadish; Krishna Gopal; Pedicone Lisa; Hardalo Catherine; Perfect John R
Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;44(1):2-12.
2007: Hope William W; Drusano George L; Moore Caroline B; Sharp Andrew; Louie Arnold; Walsh Thomas J; Denning David W; Warn Peter A
Effect of neutropenia and treatment delay on the response to antifungal agents in experimental disseminated candidiasis.
Antimicrobial agents and chemotherapy 2007;51(1):285-95.
2006: Almyroudis Nikolaos G; Kontoyiannis Dimitrios P; Sepkowitz Kent A; DePauw Ben E; Walsh Thomas J; Segal Brahm H
Issues related to the design and interpretation of clinical trials of salvage therapy for invasive mold infection.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;43(11):1449-55.
2006: O'Shaughnessy Elizabeth M; Meletiadis Joseph; Stergiopoulou Theodouli; Demchok Joanne P; Walsh Thomas J
Antifungal interactions within the triple combination of amphotericin B, caspofungin and voriconazole against Aspergillus species.
The Journal of antimicrobial chemotherapy 2006;58(6):1168-76.
2006: Ghannoum M A; Arthington-Skaggs B; Chaturvedi V; Espinel-Ingroff A; Pfaller M A; Rennie R; Rinaldi M G; Walsh T J
Interlaboratory study of quality control isolates for a broth microdilution method (modified CLSI M38-A) for testing susceptibilities of dermatophytes to antifungals.
Journal of clinical microbiology 2006;44(12):4353-6.
2006: Chiou Christine C; Seibel Nita L; Derito Francis A; Bulas Dorothy; Walsh Thomas J; Groll Andreas H
Concomitant Candida epiglottitis and disseminated Varicella zoster virus infection associated with acute lymphoblastic leukemia.
Journal of pediatric hematology/oncology : official journal of the American Society of Pediatric Hematology/Oncology 2006;28(11):757-9.
2006: Hope William W; Warn Peter A; Sharp Andrew; Howard Susan; Kasai Miki; Louie Arnold; Walsh Thomas J; Drusano George L; Denning David W
Derivation of an in vivo drug exposure breakpoint for flucytosine against Candida albicans and Impact of the MIC, growth rate, and resistance genotype on the antifungal effect.
Antimicrobial agents and chemotherapy 2006;50(11):3680-8.
2006: Meletiadis Joseph; Chanock Stephen; Walsh Thomas J
Human pharmacogenomic variations and their implications for antifungal efficacy.
Clinical microbiology reviews 2006;19(4):763-87.
2006: Groll Andreas H; Lyman Caron A; Petraitis Vidmantas; Petraitiene Ruta; Armstrong Derek; Mickiene Diana; Alfaro Raul M; Schaufele Robert L; Sein Tin; Bacher John; Walsh Thomas J
Compartmentalized intrapulmonary pharmacokinetics of amphotericin B and its lipid formulations.
Antimicrobial agents and chemotherapy 2006;50(10):3418-23.
2006: Meletiadis Joseph; Petraitis Vidmantas; Petraitiene Ruta; Lin Pengxin; Stergiopoulou Theodouli; Kelaher Amy M; Sein Tin; Schaufele Robert L; Bacher John; Walsh Thomas J
Triazole-polyene antagonism in experimental invasive pulmonary aspergillosis: in vitro and in vivo correlation.
The Journal of infectious diseases 2006;194(7):1008-18.
2006: Page Kathleen R; Sifakis Frangiscos; Montes de Oca Ruben; Cronin Wendy A; Doherty Meg C; Federline Lynn; Bur Sarah; Walsh Thomas; Karney Walter; Milman James; Baruch Nancy; Adelakun Akintoye; Dorman Susan E
Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis: a retrospective study.
Archives of internal medicine 2006;166(17):1863-70.
2006: Steinbach William J; Walsh Thomas J
Mycoses in pediatric patients.
Infectious disease clinics of North America 2006;20(3):663-78.
2006: Walsh Thomas J; Orsega Susan; Banks David
Lessons from Hurricane Rita: organizing to provide medical care during a natural disaster.
Annals of internal medicine 2006;145(6):468-70.
2006: Antachopoulos Charalampos; Meletiadis Joseph; Roilides Emmanuel; Sein Tin; Sutton Deanna A; Wickes Brian L; Rinaldi Michael G; Merz William G; Shea Yvonne R; Walsh Thomas J
Relationship between metabolism and biomass of medically important zygomycetes.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2006;44(5):429-38.
2006: Francesconi Andrea; Kasai Miki; Petraitiene Ruta; Petraitis Vidmantas; Kelaher Amy M; Schaufele Robert; Hope William W; Shea Yvonne R; Bacher John; Walsh Thomas J
Characterization and comparison of galactomannan enzyme immunoassay and quantitative real-time PCR assay for detection of Aspergillus fumigatus in bronchoalveolar lavage fluid from experimental invasive pulmonary aspergillosis.
Journal of clinical microbiology 2006;44(7):2475-80.
2006: Petraitis Vidmantas; Petraitiene Ruta; Solomon Jeffrey; Kelaher Amy M; Murray Heidi A; Mya-San Christine; Bhandary Avi K; Sein Tin; Avila Nilo A; Basevicius Algidas; Bacher John; Walsh Thomas J
Multidimensional volumetric imaging of pulmonary infiltrates for measuring therapeutic response to antifungal therapy in experimental invasive pulmonary aspergillosis.
Antimicrobial agents and chemotherapy 2006;50(4):1510-7.
2006: Panicker Jyoti; Walsh Thomas; Kamani Naynesh
Recurrent central nervous system blastomycosis in an immunocompetent child treated successfully with sequential liposomal amphotericin B and voriconazole.
The Pediatric infectious disease journal 2006;25(4):377-9.
2006: Cortez Karoll J; Lyman Caron A; Kottilil Shyam; Kim Hee Sup; Roilides Emmanuel; Yang Jun; Fullmer Brandie; Lempicki Richard; Walsh Thomas J
Functional genomics of innate host defense molecules in normal human monocytes in response to Aspergillus fumigatus.
Infection and immunity 2006;74(4):2353-65.
2006: Zaoutis Theoklis E; Heydon Kateri; Chu Jaclyn H; Walsh Thomas J; Steinbach William J
Epidemiology, outcomes, and costs of invasive aspergillosis in immunocompromised children in the United States, 2000.
Pediatrics 2006;117(4):e711-6.
2006: Segal Brahm H; Walsh Thomas J
Current approaches to diagnosis and treatment of invasive aspergillosis.
American journal of respiratory and critical care medicine 2006;173(7):707-17.
2006: de Pauw B E; Sable C A; Walsh T J; Lupinacci R J; Bourque M R; Wise B A; Nguyen B-Y; DiNubile M J; Teppler H
Impact of alternate definitions of fever resolution on the composite endpoint in clinical trials of empirical antifungal therapy for neutropenic patients with persistent fever: analysis of results from the Caspofungin Empirical Therapy Study.
Transplant infectious disease : an official journal of the Transplantation Society 2006;8(1):31-7.
2006: La Via William V; Lambert James L; Pelletier Michael J; Morookian John Michael; Sirk Shannon J; Mickiene Diana; Walsh Thomas J; Borchert Mark S
Measurement of amphotericin B concentration by resonant Raman spectroscopy--a novel technique that may be useful for non-invasive monitoring.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2006;44(2):169-74.
2006: Pfaller M A; Diekema D J; Rex J H; Espinel-Ingroff A; Johnson E M; Andes D; Chaturvedi V; Ghannoum M A; Odds F C; Rinaldi M G; Sheehan D J; Troke P; Walsh T J; Warnock D W
Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints.
Journal of clinical microbiology 2006;44(3):819-26.
2006: Dotis J; Simitsopoulou M; Dalakiouridou M; Konstantinou T; Taparkou A; Kanakoudi-Tsakalidou F; Walsh T J; Roilides E
Effects of lipid formulations of amphotericin B on activity of human monocytes against Aspergillus fumigatus.
Antimicrobial agents and chemotherapy 2006;50(3):868-73.
2006: Chu Jaclyn H; Feudtner Chris; Heydon Kateri; Walsh Thomas J; Zaoutis Theoklis E
Hospitalizations for endemic mycoses: a population-based national study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;42(6):822-5.
2006: Roilides Emmanuel; Lyman Caron A; Armstrong Derek; Stergiopoulou Theodouli; Petraitiene Ruta; Walsh Thomas J
Deoxycholate amphotericin B and amphotericin B lipid complex exert additive antifungal activity in combination with pulmonary alveolar macrophages against Fusarium solani.
Mycoses 2006;49(2):109-13.
2006: Antachopoulos Charalampos; Meletiadis Joseph; Roilides Emmanuel; Sein Tin; Walsh Thomas J
Rapid susceptibility testing of medically important zygomycetes by XTT assay.
Journal of clinical microbiology 2006;44(2):553-60.
2006: Benjamin Daniel K; Driscoll Timothy; Seibel Nita L; Gonzalez Corina E; Roden Maureen M; Kilaru Rahki; Clark Kay; Dowell James A; Schranz Jennifer; Walsh Thomas J
Safety and pharmacokinetics of intravenous anidulafungin in children with neutropenia at high risk for invasive fungal infections.
Antimicrobial agents and chemotherapy 2006;50(2):632-8.
2006: Dennis Carly G; Greco William R; Brun Yseult; Youn Richard; Slocum Harry K; Bernacki Ralph J; Lewis Russell; Wiederhold Nathan; Holland Steven M; Petraitiene Ruta; Walsh Thomas J; Segal Brahm H
Effect of amphotericin B and micafungin combination on survival, histopathology, and fungal burden in experimental aspergillosis in the p47phox-/- mouse model of chronic granulomatous disease.
Antimicrobial agents and chemotherapy 2006;50(2):422-7.
2006: Segal Brahm H; Kwon-Chung June; Walsh Thomas J; Klein Bruce S; Battiwalla Minoo; Almyroudis Nikolaos G; Holland Steven M; Romani Luigina
Immunotherapy for fungal infections.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;42(4):507-15.
2006: Kasai Miki; Francesconi Andrea; Petraitiene Ruta; Petraitis Vidmantas; Kelaher Amy M; Kim Hee-Sup; Meletiadis Joseph; Sein Tin; Bacher John; Walsh Thomas J
Use of quantitative real-time PCR to study the kinetics of extracellular DNA released from Candida albicans, with implications for diagnosis of invasive Candidiasis.
Journal of clinical microbiology 2006;44(1):143-50.
2006: De Lucca A J; Bland J M; Boue S; Vigo C B; Cleveland T E; Walsh T J
Synergism of CAY-1 with amphotericin B and itraconazole.
Chemotherapy 2006;52(6):285-7.
2006: Groll Andreas H; Walsh Thomas J
Antifungal efficacy and pharmacodynamics of posaconazole in experimental models of invasive fungal infections.
Mycoses 2006;49 Suppl 1():7-16.
2005: Würthwein Gudrun; Groll Andreas H; Hempel Georg; Adler-Shohet Felice C; Lieberman Jay M; Walsh Thomas J
Population pharmacokinetics of amphotericin B lipid complex in neonates.
Antimicrobial agents and chemotherapy 2005;49(12):5092-8.
2005: Walsh Thomas J; Adamson Peter C; Seibel Nita L; Flynn Patricia M; Neely Michael N; Schwartz Cindy; Shad Aziza; Kaplan Sheldon L; Roden Maureen M; Stone Julie A; Miller Alisha; Bradshaw Susan K; Li Susan X; Sable Carole A; Kartsonis Nicholas A
Pharmacokinetics, safety, and tolerability of caspofungin in children and adolescents.
Antimicrobial agents and chemotherapy 2005;49(11):4536-45.
2005: Zaoutis Theoklis E; Argon Jesse; Chu Jaclyn; Berlin Jesse A; Walsh Thomas J; Feudtner Chris
The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;41(9):1232-9.
2005: Groll Andreas H; Mickiene Diana; Petraitis Vidmantas; Petraitiene Ruta; Kelaher Amy; Sarafandi Alia; Wuerthwein Gudrun; Bacher John; Walsh Thomas J
Compartmental pharmacokinetics and tissue distribution of the antifungal triazole ravuconazole following intravenous administration of its di-lysine phosphoester prodrug (BMS-379224) in rabbits.
The Journal of antimicrobial chemotherapy 2005;56(5):899-907.
2005: Pannaraj Pia S; Walsh Thomas J; Baker Carol J
Advances in antifungal therapy.
The Pediatric infectious disease journal 2005;24(10):921-2.
2005: Hope W W; Walsh T J; Denning D W
Laboratory diagnosis of invasive aspergillosis.
The Lancet infectious diseases 2005;5(10):609-22.
2005: Pelletier René; Alarie Isabelle; Lagacé Réal; Walsh Thomas J
Emergence of disseminated candidiasis caused by Candida krusei during treatment with caspofungin: case report and review of literature.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2005;43(6):559-64.
2005: Roden Maureen M; Zaoutis Theoklis E; Buchanan Wendy L; Knudsen Tena A; Sarkisova Tatyana A; Schaufele Robert L; Sein Michael; Sein Tin; Chiou Christine C; Chu Jaclyn H; Kontoyiannis Dimitrios P; Walsh Thomas J
Epidemiology and outcome of zygomycosis: a review of 929 reported cases.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;41(5):634-53.
2005: Groll Andreas H; Walsh Thomas J
Posaconazole: clinical pharmacology and potential for management of fungal infections.
Expert review of anti-infective therapy 2005;3(4):467-87.
2005: Zaoutis Theoklis E; Coffin Susan E; Chu Jaclyn H; Heydon Kateri; Zhao Huaqing; Greves H Mollie; Walsh Thomas J
Risk factors for mortality in children with candidemia.
The Pediatric infectious disease journal 2005;24(8):736-9.
2005: Peter Joanne; Armstrong Derek; Lyman Caron A; Walsh Thomas J
Use of fluorescent probes to determine MICs of amphotericin B and caspofungin against Candida spp. and Aspergillus spp.
Journal of clinical microbiology 2005;43(8):3788-92.
2005: Seibel Nita L; Schwartz Cindy; Arrieta Antonio; Flynn Patricia; Shad Aziza; Albano Edith; Keirns James; Lau Wendi M; Facklam David P; Buell Donald N; Walsh Thomas J
Safety, tolerability, and pharmacokinetics of Micafungin (FK463) in febrile neutropenic pediatric patients.
Antimicrobial agents and chemotherapy 2005;49(8):3317-24.
2005: Zaoutis Theoklis E; Foraker Elyse; McGowan Karin L; Mortensen Joel; Campos Joseph; Walsh Thomas J; Klein Joel D
Antifungal susceptibility of Candida spp. isolated from pediatric patients: a survey of 4 children's hospitals.
Diagnostic microbiology and infectious disease 2005;52(4):295-8.
2005: El Saleeby Chadi M; Allison Kim J; Knapp Katherine M; Walsh Thomas J; Hayden Randall T
Discordant rise in galactomannan antigenemia in a patient with resolving Aspergillosis, renal failure, and ongoing hemodialysis.
Journal of clinical microbiology 2005;43(7):3560-3.
2005: Winn Richard M; Gil-Lamaignere Cristina; Roilides Emmanuel; Simitsopoulou Maria; Lyman Caron A; Maloukou Avgi; Walsh Thomas J
Effects of interleukin-15 on antifungal responses of human polymorphonuclear leukocytes against Fusarium spp. and Scedosporium spp.
Cytokine 2005;31(1):1-8.
2005: Dignani M Cecilia; Rex John H; Chan Ka-Wah; Dow Gordon; deMagalhaes-Silverman Margarida; Maddox AnneMarie; Walsh Thomas; Anaissie Elias
Immunomodulation with interferon-gamma and colony-stimulating factors for refractory fungal infections in patients with leukemia.
Cancer 2005;104(1):199-204.
2005: Choi Eun Hwa; Taylor James G; Foster Charles B; Walsh Thomas J; Anttila Veli-Jukka; Ruutu Tapani; Palotie Aarno; Chanock Stephen J
Common polymorphisms in critical genes of innate immunity do not contribute to the risk for chronic disseminated candidiasis in adult leukemia patients.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2005;43(4):349-53.
2005: Kim Hee Sup; Choi Eun Hwa; Khan Javed; Roilides Emmanuel; Francesconi Andrea; Kasai Miki; Sein Tin; Schaufele Robert L; Sakurai Kenichi; Son Chang Gue; Greer Braden T; Chanock Stephen; Lyman Caron A; Walsh Thomas J
Expression of genes encoding innate host defense molecules in normal human monocytes in response to Candida albicans.
Infection and immunity 2005;73(6):3714-24.
2005: Segal Brahm H; Barnhart Lisa A; Anderson Victoria L; Walsh Thomas J; Malech Harry L; Holland Steven M
Posaconazole as salvage therapy in patients with chronic granulomatous disease and invasive filamentous fungal infection.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;40(11):1684-8.
2005: Walsh T J; Roilides E; Cortez K; Kottilil S; Bailey J; Lyman C A
Control, immunoregulation, and expression of innate pulmonary host defenses against Aspergillus fumigatus.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2005;43 Suppl 1():S165-72.
2005: Hope W W; Walsh T J; Denning D W
The invasive and saprophytic syndromes due to Aspergillus spp.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2005;43 Suppl 1():S207-38.
2005: Morgan J; Wannemuehler K A; Marr K A; Hadley S; Kontoyiannis D P; Walsh T J; Fridkin S K; Pappas P G; Warnock D W
Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2005;43 Suppl 1():S49-58.
2005: Gil-Lamaignere Cristina; Winn Richard M; Simitsopoulou Maria; Maloukou Avgi; Walsh Thomas J; Roilides Emmanuel
Inteferon gamma and granulocyte-macrophage colony-stimulating factor augment the antifungal activity of human polymorphonuclear leukocytes against Scedosporium spp.: comparison with Aspergillus spp.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2005;43(3):253-60.
2005: Petraitiene Ruta; Petraitis Vidmantas; Kelaher Amy M; Sarafandi Alia A; Mickiene Diana; Groll Andreas H; Sein Tin; Bacher John; Walsh Thomas J
Efficacy, plasma pharmacokinetics, and safety of icofungipen, an inhibitor of Candida isoleucyl-tRNA synthetase, in treatment of experimental disseminated candidiasis in persistently neutropenic rabbits.
Antimicrobial agents and chemotherapy 2005;49(5):2084-92.
2005: Groll Andreas H; Stergiopoulou Theodouli; Roilides Emmanuel; Walsh Thomas J
Micafungin: pharmacology, experimental therapeutics and clinical applications.
Expert opinion on investigational drugs 2005;14(4):489-509.
2005: Petraitis Vidmantas; Petraitiene Ruta; Lin Pengxin; Calis Karim; Kelaher Amy M; Muray Heidi A; Mya-San Christine; Mickiene Diana; Bacher John; Walsh Thomas J
Efficacy and safety of generic amphotericin B in experimental pulmonary aspergillosis.
Antimicrobial agents and chemotherapy 2005;49(4):1642-5.
2005: Simitsopoulou M; Roilides E; Dotis J; Dalakiouridou M; Dudkova F; Andreadou E; Walsh T J
Differential expression of cytokines and chemokines in human monocytes induced by lipid formulations of amphotericin B.
Antimicrobial agents and chemotherapy 2005;49(4):1397-403.
2005: Kontoyiannis Dimitrios P; Lionakis Michail S; Lewis Russell E; Chamilos Georgios; Healy Mimi; Perego Cheryl; Safdar Amar; Kantarjian Hagop; Champlin Richard; Walsh Thomas J; Raad Issam I
Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases.
The Journal of infectious diseases 2005;191(8):1350-60.
2005: Gil-Lamaignere Cristina; Simitsopoulou Maria; Roilides Emmanuel; Maloukou Avgi; Winn Richard M; Walsh Thomas J
Interferon- gamma and granulocyte-macrophage colony-stimulating factor augment the activity of polymorphonuclear leukocytes against medically important zygomycetes.
The Journal of infectious diseases 2005;191(7):1180-7.
2005: Yamagishi Hisako; Fitzgerald Deirdre H; Sein Tin; Walsh Thomas J; O'Connell Brian C
Saliva affects the antifungal activity of exogenously added histatin 3 towards Candida albicans.
FEMS microbiology letters 2005;244(1):207-12.
2005: Shaukat Aasma; Bakri Faris; Young Paul; Hahn Theresa; Ball Donna; Baer Maria R; Wetzler Meir; Slack James L; Loud Peter; Czuczman Myron; McCarthy Philip L; Walsh Thomas J; Segal Brahm H
Invasive filamentous fungal infections in allogeneic hematopoietic stem cell transplant recipients after recovery from neutropenia: clinical, radiologic, and pathologic characteristics.
Mycopathologia 2005;159(2):181-8.
2005: Wiley Joseph M; Seibel Nita L; Walsh Thomas J
Efficacy and safety of amphotericin B lipid complex in 548 children and adolescents with invasive fungal infections.
The Pediatric infectious disease journal 2005;24(2):167-74.
2005: Cortez Karoll J; Groll Andreas H; Walsh Thomas J
Resources for medical mycology on the World Wide Web.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;40(3):437-50.
2005: Antachopoulos Charalampos; Walsh Thomas J
New agents for invasive mycoses in children.
Current opinion in pediatrics 2005;17(1):78-87.
2005: Kurtzman Cletus P; Robnett Christie J; Ward Jerrold M; Brayton Cory; Gorelick Peter; Walsh Thomas J
Multigene phylogenetic analysis of pathogenic candida species in the Kazachstania (Arxiozyma) telluris complex and description of their ascosporic states as Kazachstania bovina sp. nov., K. heterogenica sp. nov., K. pintolopesii sp. nov., and K. slooffiae sp. nov.
Journal of clinical microbiology 2005;43(1):101-11.
2004: Odio Carla M; Araya Roberto; Pinto Luis E; Castro Carlos E; Vasquez Sergio; Alfaro Braulio; Sàenz Alberto; Herrera Marco L; Walsh Thomas J
Caspofungin therapy of neonates with invasive candidiasis.
The Pediatric infectious disease journal 2004;23(12):1093-7.
2004: Maertens Johan; Raad Issam; Petrikkos George; Boogaerts Marc; Selleslag Dominik; Petersen Finn B; Sable Carole A; Kartsonis Nicholas A; Ngai Angela; Taylor Arlene; Patterson Thomas F; Denning David W; Walsh Thomas J;
Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;39(11):1563-71.
2004: van Burik Jo-Anne H; Ratanatharathorn Voravit; Stepan Daniel E; Miller Carole B; Lipton Jeffrey H; Vesole David H; Bunin Nancy; Wall Donna A; Hiemenz John W; Satoi Yoichi; Lee Jeanette M; Walsh Thomas J;
Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;39(10):1407-16.
2004: O'Donnell Kerry; Sutton Deanna A; Rinaldi Michael G; Magnon Karen C; Cox Patricia A; Revankar Sanjay G; Sanche Stephen; Geiser David M; Juba Jean H; van Burik Jo-Anne H; Padhye Arvind; Anaissie Elias J; Francesconi Andrea; Walsh Thomas J; Robinson Jody S
Genetic diversity of human pathogenic members of the Fusarium oxysporum complex inferred from multilocus DNA sequence data and amplified fragment length polymorphism analyses: evidence for the recent dispersion of a geographically widespread clonal lineage and nosocomial origin.
Journal of clinical microbiology 2004;42(11):5109-20.
2004: Forrest Graeme N; Walsh Thomas J
Approaches to management of invasive fungal infections in patients with hematologic malignancies.
Supportive cancer therapy 2004;2(1):21-30.
2004: Walsh Thomas J; Shoham Shmuel; Petraitiene Ruta; Sein Tin; Schaufele Robert; Kelaher Amy; Murray Heidi; Mya-San Christine; Bacher John; Petraitis Vidmantas
Detection of galactomannan antigenemia in patients receiving piperacillin-tazobactam and correlations between in vitro, in vivo, and clinical properties of the drug-antigen interaction.
Journal of clinical microbiology 2004;42(10):4744-8.
2004: Petraitis Vidmantas; Petraitiene Ruta; Kelaher Amy M; Sarafandi Alia A; Sein Tin; Mickiene Diana; Bacher John; Groll Andreas H; Walsh Thomas J
Efficacy of PLD-118, a novel inhibitor of candida isoleucyl-tRNA synthetase, against experimental oropharyngeal and esophageal candidiasis caused by fluconazole-resistant C. albicans.
Antimicrobial agents and chemotherapy 2004;48(10):3959-67.
2004: Krause David S; Simjee A E; van Rensburg Christo; Viljoen Johann; Walsh Thomas J; Goldstein Beth P; Wible Michele; Henkel Timothy
A randomized, double-blind trial of anidulafungin versus fluconazole for the treatment of esophageal candidiasis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;39(6):770-5.
2004: Walsh Thomas J; Teppler Hedy; Donowitz Gerald R; Maertens Johan A; Baden Lindsey R; Dmoszynska Anna; Cornely Oliver A; Bourque Michael R; Lupinacci Robert J; Sable Carole A; dePauw Ben E
Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia.
The New England journal of medicine 2004;351(14):1391-402.
2004: Kordy Faisal N; Al-Mohsen Ibrahim Z; Hashem Fuad; Almodovar Edna; Al Hajjar Sami; Walsh Thomas J
Successful treatment of a child with posttraumatic necrotizing fasciitis caused by Apophysomyces elegans: case report and review of literature.
The Pediatric infectious disease journal 2004;23(9):877-9.
2004: Steinbach William J; Perfect John R; Schell Wiley A; Walsh Thomas J; Benjamin Daniel K
In vitro analyses, animal models, and 60 clinical cases of invasive Aspergillus terreus infection.
Antimicrobial agents and chemotherapy 2004;48(9):3217-25.
2004: Abzug Mark J; Walsh Thomas J
Interferon-gamma and colony-stimulating factors as adjuvant therapy for refractory fungal infections in children.
The Pediatric infectious disease journal 2004;23(8):769-73.
2004: Marr Kieren A; Balajee S Arunmozhi; McLaughlin Lisa; Tabouret Marc; Bentsen Christopher; Walsh Thomas J
Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance.
The Journal of infectious diseases 2004;190(3):641-9.
2004: Steinbach William J; Benjamin Daniel K; Kontoyiannis Dimitrios P; Perfect John R; Lutsar Irja; Marr Kieren A; Lionakis Michail S; Torres Harrys A; Jafri Hasan; Walsh Thomas J
Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;39(2):192-8.
2004: Legrand Melanie; Lephart Paul; Forche Anja; Mueller Frank-Michael C; Walsh T; Magee P T; Magee Beatrice B
Homozygosity at the MTL locus in clinical strains of Candida albicans: karyotypic rearrangements and tetraploid formation.
Molecular microbiology 2004;52(5):1451-62.
2004: Walsh Thomas J; Karlsson Mats O; Driscoll Timothy; Arguedas Adriano G; Adamson Peter; Saez-Llorens Xavier; Vora Ajay J; Arrieta Antonio C; Blumer Jeffrey; Lutsar Irja; Milligan Peter; Wood Nolan
Pharmacokinetics and safety of intravenous voriconazole in children after single- or multiple-dose administration.
Antimicrobial agents and chemotherapy 2004;48(6):2166-72.
2004: Petraitiene Ruta; Petraitis Vidmantas; Lyman Caron A; Groll Andreas H; Mickiene Diana; Peter Joanne; Bacher John; Roussillon Kristin; Hemmings Melissa; Armstrong Derrek; Avila Nilo A; Walsh Thomas J
Efficacy, safety, and plasma pharmacokinetics of escalating dosages of intravenously administered ravuconazole lysine phosphoester for treatment of experimental pulmonary aspergillosis in persistently neutropenic rabbits.
Antimicrobial agents and chemotherapy 2004;48(4):1188-96.
2004: Srinivasan R; Chakrabarti S; Walsh T; Igarashi T; Takahashi Y; Kleiner D; Donohue T; Shalabi R; Carvallo C; Barrett A J; Geller N; Childs R
Improved survival in steroid-refractory acute graft versus host disease after non-myeloablative allogeneic transplantation using a daclizumab-based strategy with comprehensive infection prophylaxis.
British journal of haematology 2004;124(6):777-86.
2004: Walsh T J; Groll A; Hiemenz J; Fleming R; Roilides E; Anaissie E
Infections due to emerging and uncommon medically important fungal pathogens.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2004;10 Suppl 1():48-66.
2004: Roilides Emmanuel; Walsh Thomas
Recombinant cytokines in augmentation and immunomodulation of host defenses against Candida spp.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2004;42(1):1-13.
2004: Pappas Peter G; Rex John H; Sobel Jack D; Filler Scott G; Dismukes William E; Walsh Thomas J; Edwards John E;
Guidelines for treatment of candidiasis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;38(2):161-89.
2004: Boucher Helen W; Groll Andreas H; Chiou Christine C; Walsh Thomas J
Newer systemic antifungal agents : pharmacokinetics, safety and efficacy.
Drugs 2004;64(18):1997-2020.
2003: Steinbach William J; Mitchell Thomas G; Schell Wiley A; Espinel-Ingroff Ana; Coico Richard F; Walsh Thomas J; Perfect John R
Status of medical mycology education.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2003;41(6):457-67.
2003: O'Sullivan Cathal E; Kasai Miki; Francesconi Andrea; Petraitis Vidmantas; Petraitiene Ruta; Kelaher Amy M; Sarafandi Alia A; Walsh Thomas J
Development and validation of a quantitative real-time PCR assay using fluorescence resonance energy transfer technology for detection of Aspergillus fumigatus in experimental invasive pulmonary aspergillosis.
Journal of clinical microbiology 2003;41(12):5676-82.
2003: Groll Andreas H; Mickiene Diana; Petraitis Vidmantas; Petraitiene Ruta; Alfaro Raul M; King Christine; Piscitelli Stephen C; Walsh Thomas J
Comparative drug disposition, urinary pharmacokinetics, and renal effects of multilamellar liposomal nystatin and amphotericin B deoxycholate in rabbits.
Antimicrobial agents and chemotherapy 2003;47(12):3917-25.
2003: Gil-Lamaignere Cristina; Roilides Emmanuel; Lyman Caron A; Simitsopoulou Maria; Stergiopoulou Theodouli; Maloukou Avgi; Walsh Thomas J
Human phagocytic cell responses to Scedosporium apiospermum (Pseudallescheria boydii): variable susceptibility to oxidative injury.
Infection and immunity 2003;71(11):6472-8.
2003: Benjamin Daniel K; Poole Charles; Steinbach William J; Rowen Judith L; Walsh Thomas J
Neonatal candidemia and end-organ damage: a critical appraisal of the literature using meta-analytic techniques.
Pediatrics 2003;112(3 Pt 1):634-40.
2003: Benjamin Daniel K; DeLong Elizabeth R; Steinbach William J; Cotton Charles M; Walsh Thomas J; Clark Reese H
Empirical therapy for neonatal candidemia in very low birth weight infants.
Pediatrics 2003;112(3 Pt 1):543-7.
2003: Winn Richard M; Gil-Lamaignere Cristina; Roilides Emmanuel; Simitsopoulou Maria; Lyman Caron A; Maloukou Avgi; Walsh Thomas J
Selective effects of interleukin (IL)-15 on antifungal activity and IL-8 release by polymorphonuclear leukocytes in response to hyphae of Aspergillus species.
The Journal of infectious diseases 2003;188(4):585-90.
2003: Walsh Thomas J; Petraitis Vidmantas; Petraitiene Ruta; Field-Ridley Aida; Sutton Deanna; Ghannoum Mahmoud; Sein Tin; Schaufele Robert; Peter Joanne; Bacher John; Casler Heather; Armstrong Derek; Espinel-Ingroff Anna; Rinaldi Michael G; Lyman Caron A
Experimental pulmonary aspergillosis due to Aspergillus terreus: pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B.
The Journal of infectious diseases 2003;188(2):305-19.
2003: Cortez Karoll J; Walsh Thomas J; Bennett John E
Successful treatment of coccidioidal meningitis with voriconazole.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;36(12):1619-22.
2003: Petraitis Vidmantas; Petraitiene Ruta; Sarafandi Alia A; Kelaher Amy M; Lyman Caron A; Casler Heather E; Sein Tin; Groll Andreas H; Bacher John; Avila Nilo A; Walsh Thomas J
Combination therapy in treatment of experimental pulmonary aspergillosis: synergistic interaction between an antifungal triazole and an echinocandin.
The Journal of infectious diseases 2003;187(12):1834-43.
2003: Roden Maureen M; Nelson Lucienne D; Knudsen Tena A; Jarosinski Paul F; Starling Judith M; Shiflett Stacey E; Calis Karim; DeChristoforo Robert; Donowitz Gerald R; Buell Donald; Walsh Thomas J
Triad of acute infusion-related reactions associated with liposomal amphotericin B: analysis of clinical and epidemiological characteristics.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;36(10):1213-20.
2003: Roilides Emmanuel; Lyman Caron A; Sein Tin; Petraitiene Ruta; Walsh Thomas J
Macrophage colony-stimulating factor enhances phagocytosis and oxidative burst of mononuclear phagocytes against Penicillium marneffei conidia.
FEMS immunology and medical microbiology 2003;36(1-2):19-26.
2003: Perfect John R; Marr Kieren A; Walsh Thomas J; Greenberg Richard N; DuPont Bertrand; de la Torre-Cisneros Juliàn; Just-Nübling Gudrun; Schlamm Haran T; Lutsar Irja; Espinel-Ingroff Ana; Johnson Elizabeth
Voriconazole treatment for less-common, emerging, or refractory fungal infections.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;36(9):1122-31.
2003: Bennett John E; Kauffman Carol; Walsh Thomas; de Pauw Ben; Dismukes William; Galgiani John; Glauser Michel; Herbrecht Raoul; Lee Jeannette; Pappas Peter; Powers John; Rex John; Verweij Paul; Viscoli Claudio
Forum report: issues in the evaluation of diagnostic tests, use of historical controls, and merits of the current multicenter collaborative groups.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;36(Suppl 3):S123-7.
2003: Bennett John E; Powers John; Walsh Thomas; Viscoli Claudio; de Pauw Ben; Dismukes William; Galgiani John; Glauser Michel; Herbrecht Raoul; Kauffman Carol; Lee Jeannette; Pappas Peter; Rex John; Verweij Paul
Forum report: issues in clinical trials of empirical antifungal therapy in treating febrile neutropenic patients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;36(Suppl 3):S117-22.
2003: Bennett John E; Powers John; de Pauw Ben; Dismukes William; Galgiani John; Glauser Michel; Herbrecht Raoul; Kauffman Carol; Lee Jeannette; Pappas Peter; Rex John; Verweij Paul; Viscoli Claudio; Walsh Thomas
Forum report: issues in the design of trials of drugs for the treatment of invasive aspergillosis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;36(Suppl 3):S113-6.
2003: Choi Eun Hwa; Foster Charles B; Taylor James G; Erichsen Hans Christian; Chen Renee A; Walsh Thomas J; Anttila Veli-Jukka; Ruutu Tapani; Palotie Aarno; Chanock Stephen J
Association between chronic disseminated candidiasis in adult acute leukemia and common IL4 promoter haplotypes.
The Journal of infectious diseases 2003;187(7):1153-6.
2003: Anaissie Elias J; Stratton Shawna L; Dignani M Cecilia; Lee Choon-kee; Summerbell Richard C; Rex John H; Monson Thomas P; Walsh Thomas J
Pathogenic molds (including Aspergillus species) in hospital water distribution systems: a 3-year prospective study and clinical implications for patients with hematologic malignancies.
Blood 2003;101(7):2542-6.
2003: Groll Andreas H; Gea-Banacloche Juan C; Glasmacher Axel; Just-Nuebling Gudrun; Maschmeyer Georg; Walsh Thomas J
Clinical pharmacology of antifungal compounds.
Infectious disease clinics of North America 2003;17(1):159-91, ix.
2003: Roilides Emmanuel; Farmaki Evangelia; Evdoridou Joanna; Francesconi Andrea; Kasai Miki; Filioti Joanna; Tsivitanidou Maria; Sofianou Danai; Kremenopoulos George; Walsh Thomas J
Candida tropicalis in a neonatal intensive care unit: epidemiologic and molecular analysis of an outbreak of infection with an uncommon neonatal pathogen.
Journal of clinical microbiology 2003;41(2):735-41.
2002: Fleming Rhonda V; Walsh Thomas J; Anaissie Elias J
Emerging and less common fungal pathogens.
Infectious disease clinics of North America 2002;16(4):915-33, vi-vii.
2002: Walsh Thomas J
Echinocandins--an advance in the primary treatment of invasive candidiasis.
The New England journal of medicine 2002;347(25):2070-2.
2002: Feld Ronald; Paesmans Marianne; Freifeld Alison G; Klastersky Jean; Pizzo Philip A; Rolston Kenneth V I; Rubenstein Edward; Talcott James A; Walsh Thomas J;
Methodology for clinical trials involving patients with cancer who have febrile neutropenia: updated guidelines of the Immunocompromised Host Society/Multinational Association for Supportive Care in Cancer, with emphasis on outpatient studies.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;35(12):1463-8.
2002: Gil-Lamaignere Cristina; Roilides Emmanuel; Maloukou Avgi; Georgopoulou Irene; Petrikkos George; Walsh Thomas J
Amphotericin B lipid complex exerts additive antifungal activity in combination with polymorphonuclear leucocytes against Scedosporium prolificans and Scedosporium apiospermum.
The Journal of antimicrobial chemotherapy 2002;50(6):1027-30.
2002: Anaissie Elias J; Stratton Shawna L; Dignani Maria Cecilia; Lee Choon-Kee; Mahfouz Tahsine H; Rex John H; Summerbell Richard C; Walsh Thomas J
Cleaning patient shower facilities: a novel approach to reducing patient exposure to aerosolized Aspergillus species and other opportunistic molds.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;35(8):E86-8.
2002: Espinel-Ingroff A; Fothergill A; Peter J; Rinaldi M G; Walsh T J
Testing conditions for determination of minimum fungicidal concentrations of new and established antifungal agents for Aspergillus spp.: NCCLS collaborative study.
Journal of clinical microbiology 2002;40(9):3204-8.
2002: Groll Andreas H; Wood Lauren; Roden Maureen; Mickiene Diana; Chiou Christine C; Townley Ellen; Dad Luqman; Piscitelli Stephen C; Walsh Thomas J
Safety, pharmacokinetics, and pharmacodynamics of cyclodextrin itraconazole in pediatric patients with oropharyngeal candidiasis.
Antimicrobial agents and chemotherapy 2002;46(8):2554-63.
2002: Gil-Lamaignere Cristina; Roilides Emmanuel; Mosquera Juan; Maloukou Avgi; Walsh Thomas J
Antifungal triazoles and polymorphonuclear leukocytes synergize to cause increased hyphal damage to Scedosporium prolificans and Scedosporium apiospermum.
Antimicrobial agents and chemotherapy 2002;46(7):2234-7.
2002: Groll Andreas H; Walsh Thomas J
Antifungal chemotherapy: advances and perspectives.
Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2002;132(23-24):303-11.
2002: Roilides Emmanuel; Lyman Caron A; Filioti Joanna; Akpogheneta Onome; Sein Tin; Lamaignere Cristina Gil; Petraitiene Ruta; Walsh Thomas J
Amphotericin B formulations exert additive antifungal activity in combination with pulmonary alveolar macrophages and polymorphonuclear leukocytes against Aspergillus fumigatus.
Antimicrobial agents and chemotherapy 2002;46(6):1974-6.
2002: Petraitis Vidmantas; Petraitiene Ruta; Groll Andreas H; Roussillon Kristin; Hemmings Melissa; Lyman Caron A; Sein Tin; Bacher John; Bekersky Ihor; Walsh Thomas J
Comparative antifungal activities and plasma pharmacokinetics of micafungin (FK463) against disseminated candidiasis and invasive pulmonary aspergillosis in persistently neutropenic rabbits.
Antimicrobial agents and chemotherapy 2002;46(6):1857-69.
2002: Chiou Christine C; Groll Andreas H; Mavrogiorgos Nikolaos; Wood Lauren V; Walsh Thomas J
Esophageal candidiasis in human immunodeficiency virus-infected pediatric patients after the introduction of highly active antiretroviral therapy.
The Pediatric infectious disease journal 2002;21(5):388-92.
2002: Walsh Thomas J; Lee Jeannette; Dismukes William E
Decisions about voriconazole versus liposomal amphotericin B.
The New England journal of medicine 2002;346(19):1499; author reply 1499.
2002: De Lucca A J; Bland J M; Vigo C B; Cushion M; Selitrennikoff C P; Peter J; Walsh T J
CAY-I, a fungicidal saponin from Capsicum sp. fruit.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2002;40(2):131-7.
2002: Walsh Thomas J; Lutsar Irja; Driscoll Timothy; Dupont Bertrand; Roden Maureen; Ghahramani Parvis; Hodges Michael; Groll Andreas H; Perfect John R
Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children.
The Pediatric infectious disease journal 2002;21(3):240-8.
2002: Anaissie Elias J; Stratton Shawna L; Dignani M Cecilia; Summerbell Richard C; Rex John H; Monson Thomas P; Spencer Trey; Kasai Miki; Francesconi Andrea; Walsh Thomas J
Pathogenic Aspergillus species recovered from a hospital water system: a 3-year prospective study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;34(6):780-9.
2002: Bekersky Ihor; Fielding Robert M; Dressler Dawna E; Lee Jean W; Buell Donald N; Walsh Thomas J
Plasma protein binding of amphotericin B and pharmacokinetics of bound versus unbound amphotericin B after administration of intravenous liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate.
Antimicrobial agents and chemotherapy 2002;46(3):834-40.
2002: Bekersky Ihor; Fielding Robert M; Dressler Dawna E; Lee Jean W; Buell Donald N; Walsh Thomas J
Pharmacokinetics, excretion, and mass balance of liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate in humans.
Antimicrobial agents and chemotherapy 2002;46(3):828-33.
2002: Walsh Thomas J; Rex John H
All catheter-related candidemia is not the same: assessment of the balance between the risks and benefits of removal of vascular catheters.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;34(5):600-2.
2002: Walsh Thomas J; Pappas Peter; Winston Drew J; Lazarus Hillard M; Petersen Finn; Raffalli John; Yanovich Saul; Stiff Patrick; Greenberg Richard; Donowitz Gerald; Schuster Mindy; Reboli Annette; Wingard John; Arndt Carola; Reinhardt John; Hadley Susan; Finberg Robert; Laverdière Michél; Perfect John; Garber Gary; Fioritoni Giuseppe; Anaissie Eli; Lee Jeanette;
Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.
The New England journal of medicine 2002;346(4):225-34.
2002: Petraitiene Ruta; Petraitis Vidmantas; Groll Andreas H; Sein Tin; Schaufele Robert L; Francesconi Andrea; Bacher John; Avila Nilo A; Walsh Thomas J
Antifungal efficacy of caspofungin (MK-0991) in experimental pulmonary aspergillosis in persistently neutropenic rabbits: pharmacokinetics, drug disposition, and relationship to galactomannan antigenemia.
Antimicrobial agents and chemotherapy 2002;46(1):12-23.
2002: Ascioglu S; Rex J H; de Pauw B; Bennett J E; Bille J; Crokaert F; Denning D W; Donnelly J P; Edwards J E; Erjavec Z; Fiere D; Lortholary O; Maertens J; Meis J F; Patterson T F; Ritter J; Selleslag D; Shah P M; Stevens D A; Walsh T J;
Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;34(1):7-14.
2001: Walsh T J; Goodman J L; Pappas P; Bekersky I; Buell D N; Roden M; Barrett J; Anaissie E J
Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: maximum tolerated dose study.
Antimicrobial agents and chemotherapy 2001;45(12):3487-96.
2001: Groll A H; Mickiene D; Petraitis V; Petraitiene R; Ibrahim K H; Piscitelli S C; Bekersky I; Walsh T J
Compartmental pharmacokinetics and tissue distribution of the antifungal echinocandin lipopeptide micafungin (FK463) in rabbits.
Antimicrobial agents and chemotherapy 2001;45(12):3322-7.
2001: Chiou C C; Mavrogiorgos N; Tillem E; Hector R; Walsh T J
Synergy, pharmacodynamics, and time-sequenced ultrastructural changes of the interaction between nikkomycin Z and the echinocandin FK463 against Aspergillus fumigatus.
Antimicrobial agents and chemotherapy 2001;45(12):3310-21.
2001: Anaissie E J; Kuchar R T; Rex J H; Francesconi A; Kasai M; Müller F M; Lozano-Chiu M; Summerbell R C; Dignani M C; Chanock S J; Walsh T J
Fusariosis associated with pathogenic fusarium species colonization of a hospital water system: a new paradigm for the epidemiology of opportunistic mold infections.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;33(11):1871-8.
2001: Djalilian A R; Smith J A; Walsh T J; Malech H L; Robinson M R
Keratitis caused by Candida glabrata in a patient with chronic granulomatous disease.
American journal of ophthalmology 2001;132(5):782-3.
2001: Petraitiene R; Petraitis V; Bacher J; Das S R; Parlow A F; Walsh T J
Cyclosporine A-induced mammary hyperplasia and hyperprolactinemia in New Zealand White rabbits.
Comparative medicine 2001;51(5):430-5.
2001: Walsh T J; Groll A H
Overview: non-fumigatus species of Aspergillus: perspectives on emerging pathogens in immunocompromised hosts.
Current opinion in investigational drugs (London, England : 2000) 2001;2(10):1366-7.
2001: Katsifa H; Tsaparidou S; Diza E; Gil-Lamaignere C; Walsh T J; Roilides E
Effects of interleukin-13 on antifungal activity of human monocytes against Candida albicans.
FEMS immunology and medical microbiology 2001;31(3):211-7.
2001: Rex J H; Pfaller M A; Walsh T J; Chaturvedi V; Espinel-Ingroff A; Ghannoum M A; Gosey L L; Odds F C; Rinaldi M G; Sheehan D J; Warnock D W
Antifungal susceptibility testing: practical aspects and current challenges.
Clinical microbiology reviews 2001;14(4):643-58, table of contents.
2001: Groll A H; Mickiene D; Petraitiene R; Petraitis V; Lyman C A; Bacher J S; Piscitelli S C; Walsh T J
Pharmacokinetic and pharmacodynamic modeling of anidulafungin (LY303366): reappraisal of its efficacy in neutropenic animal models of opportunistic mycoses using optimal plasma sampling.
Antimicrobial agents and chemotherapy 2001;45(10):2845-55.
2001: Bekersky I; Fielding R M; Dressler D E; Kline S; Buell D N; Walsh T J
Pharmacokinetics, excretion, and mass balance of 14C after administration of 14C-cholesterol-labeled AmBisome to healthy volunteers.
Journal of clinical pharmacology 2001;41(9):963-71.
2001: Groll A H; Walsh T J
Caspofungin: pharmacology, safety and therapeutic potential in superficial and invasive fungal infections.
Expert opinion on investigational drugs 2001;10(8):1545-58.
2001: Groll A H; Piscitelli S C; Walsh T J
Antifungal pharmacodynamics: concentration-effect relationships in vitro and in vivo.
Pharmacotherapy 2001;21(8 Pt 2):133S-148S.
2001: Letterio J J; Lehrnbecher T; Pollack G; Walsh T J; Chanock S J
Invasive candidiasis stimulates hepatocyte and monocyte production of active transforming growth factor beta.
Infection and immunity 2001;69(8):5115-20.
2001: Gonzalez C E; Lyman C A; Lee S; Del Guercio C; Roilides E; Bacher J; Gehrt A; Feuerstein E; Tsokos M; Walsh T J
Recombinant human macrophage colony-stimulating factor augments pulmonary host defences against Aspergillus fumigatus.
Cytokine 2001;15(2):87-95.
2001: Rex J H; Walsh T J; Nettleman M; Anaissie E J; Bennett J E; Bow E J; Carillo-Munoz A J; Chavanet P; Cloud G A; Denning D W; de Pauw B E; Edwards Jr J E; Hiemenz J W; Kauffman C A; Lopez-Berestein G; Martino P; Sobel J D; Stevens D A; Sylvester R; Tollemar J; Viscoli C; Viviani M A; Wu T
Need for alternative trial designs and evaluation strategies for therapeutic studies of invasive mycoses.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;33(1):95-106.
2001: Espinel-Ingroff A; Bartlett M; Chaturvedi V; Ghannoum M; Hazen K C; Pfaller M A; Rinaldi M; Walsh T J
Optimal susceptibility testing conditions for detection of azole resistance in Aspergillus spp.: NCCLS collaborative evaluation. National Committee for Clinical Laboratory Standards.
Antimicrobial agents and chemotherapy 2001;45(6):1828-35.
2001: Petraitiene R; Petraitis V; Groll A H; Sein T; Piscitelli S; Candelario M; Field-Ridley A; Avila N; Bacher J; Walsh T J
Antifungal activity and pharmacokinetics of posaconazole (SCH 56592) in treatment and prevention of experimental invasive pulmonary aspergillosis: correlation with galactomannan antigenemia.
Antimicrobial agents and chemotherapy 2001;45(3):857-69.
2001: Rex J H; Walsh T J; Sobel J D; Filler S G; Pappas P G; Dismukes W E; Edwards J E
Reply to Dr. Chandrasekar (Clin Infect Dis 2001; 32:320-1) and Drs. Marr and Boeckh (Clin Infect Dis 2001; 32:321).
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;32(3):518-9.
2001: Groll A H; Gullick B M; Petraitiene R; Petraitis V; Candelario M; Piscitelli S C; Walsh T J
Compartmental pharmacokinetics of the antifungal echinocandin caspofungin (MK-0991) in rabbits.
Antimicrobial agents and chemotherapy 2001;45(2):596-600.
2001: Petraitis V; Petraitiene R; Groll A H; Sein T; Schaufele R L; Lyman C A; Francesconi A; Bacher J; Piscitelli S C; Walsh T J
Dosage-dependent antifungal efficacy of V-echinocandin (LY303366) against experimental fluconazole-resistant oropharyngeal and esophageal candidiasis.
Antimicrobial agents and chemotherapy 2001;45(2):471-9.
2001: Roilides E; Sein T; Roden M; Schaufele R L; Walsh T J
Elevated serum concentrations of interleukin-10 in nonneutropenic patients with invasive aspergillosis.
The Journal of infectious diseases 2001;183(3):518-20.
2001: Groll A H; Walsh T J
Uncommon opportunistic fungi: new nosocomial threats.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2001;7 Suppl 2():8-24.
2000: Bekersky I; Boswell G W; Hiles R; Fielding R M; Buell D; Walsh T J
Safety, toxicokinetics and tissue distribution of long-term intravenous liposomal amphotericin B (AmBisome): a 91-day study in rats.
Pharmaceutical research 2000;17(12):1494-502.
2000: Robinson M R; Fine H F; Ross M L; Mont E K; Bryant-Greenwood P K; Hertle R W; Tisdale J F; Young N S; Zeichner S L; Van Waes C; Whitcup S M; Walsh T J
Sino-orbital-cerebral aspergillosis in immunocompromised pediatric patients.
The Pediatric infectious disease journal 2000;19(12):1197-203.
2000: Al-Mohsen I Z; Sutton D A; Sigler L; Almodovar E; Mahgoub N; Frayha H; Al-Hajjar S; Rinaldi M G; Walsh T J
Acrophialophora fusispora brain abscess in a child with acute lymphoblastic leukemia: review of cases and taxonomy.
Journal of clinical microbiology 2000;38(12):4569-76.
2000: Tisdale J F; Dunn D E; Geller N; Plante M; Nunez O; Dunbar C E; Barrett A J; Walsh T J; Rosenfeld S J; Young N S
High-dose cyclophosphamide in severe aplastic anaemia: a randomised trial.
Lancet 2000;356(9241):1554-9.
2000: Walsh T J; Roden M; Roilides E; Groll A
Concepts in design of comparative clinical trials of antifungal therapy in neutropenic patients.
International journal of antimicrobial agents 2000;16(2):151-6.
2000: De Lucca A J; Bland J M; Vigo C B; Jacks T J; Peter J; Walsh T J
D-cecropin B: proteolytic resistance, lethality for pathogenic fungi and binding properties.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2000;38(4):301-8.
2000: Chiou C C; Groll A H; Gonzalez C E; Callender D; Venzon D; Pizzo P A; Wood L; Walsh T J
Esophageal candidiasis in pediatric acquired immunodeficiency syndrome: clinical manifestations and risk factors.
The Pediatric infectious disease journal 2000;19(8):729-34.
2000: Müller F M; Weig M; Peter J; Walsh T J
Azole cross-resistance to ketoconazole, fluconazole, itraconazole and voriconazole in clinical Candida albicans isolates from HIV-infected children with oropharyngeal candidosis.
The Journal of antimicrobial chemotherapy 2000;46(2):338-40.
2000: Walsh T J; Jackson A J; Lee J W; Amantea M; Sein T; Bacher J; Zech L
Dose-dependent pharmacokinetics of amphotericin B lipid complex in rabbits.
Antimicrobial agents and chemotherapy 2000;44(8):2068-76.
2000: Groll A H; Giri N; Petraitis V; Petraitiene R; Candelario M; Bacher J S; Piscitelli S C; Walsh T J
Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system.
The Journal of infectious diseases 2000;182(1):274-82.
2000: Cagnoni P J; Walsh T J; Prendergast M M; Bodensteiner D; Hiemenz S; Greenberg R N; Arndt C A; Schuster M; Seibel N; Yeldandi V; Tong K B
Pharmacoeconomic analysis of liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(12):2476-83.
2000: Walsh T J; Gonzalez C E; Piscitelli S; Bacher J D; Peter J; Torres R; Shetti D; Katsov V; Kligys K; Lyman C A
Correlation between in vitro and in vivo antifungal activities in experimental fluconazole-resistant oropharyngeal and esophageal candidiasis.
Journal of clinical microbiology 2000;38(6):2369-73.
2000: Roilides E; Lyman C A; Sein T; Gonzalez C; Walsh T J
Antifungal activity of splenic, liver and pulmonary macrophages against Candida albicans and effects of macrophage colony-stimulating factor.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2000;38(2):161-8.
2000: Roilides E; Katsifa H; Tsaparidou S; Stergiopoulou T; Panteliadis C; Walsh T J
Interleukin 10 suppresses phagocytic and antihyphal activities of human neutrophils.
Cytokine 2000;12(4):379-87.
2000: Stevens D A; Kan V L; Judson M A; Morrison V A; Dummer S; Denning D W; Bennett J E; Walsh T J; Patterson T F; Pankey G A
Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2000;30(4):696-709.
2000: Rex J H; Walsh T J; Sobel J D; Filler S G; Pappas P G; Dismukes W E; Edwards J E
Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2000;30(4):662-78.
2000: Pelletier R; Peter J; Antin C; Gonzalez C; Wood L; Walsh T J
Emergence of resistance of Candida albicans to clotrimazole in human immunodeficiency virus-infected children: in vitro and clinical correlations.
Journal of clinical microbiology 2000;38(4):1563-8.
2000: Warren K E; McCully C M; Walsh T J; Balis F M
Effect of fluconazole on the pharmacokinetics of doxorubicin in nonhuman primates.
Antimicrobial agents and chemotherapy 2000;44(4):1100-1.
2000: Groll A H; Mickiene D; Werner K; Petraitiene R; Petraitis V; Calendario M; Field-Ridley A; Crisp J; Piscitelli S C; Walsh T J
Compartmental pharmacokinetics and tissue distribution of multilamellar liposomal nystatin in rabbits.
Antimicrobial agents and chemotherapy 2000;44(4):950-7.
2000: Groll A H; Mickiene D; Piscitelli S C; Walsh T J
Distribution of lipid formulations of amphotericin B into bone marrow and fat tissue in rabbits.
Antimicrobial agents and chemotherapy 2000;44(2):408-10.
2000: Walsh T J; Viviani M A; Arathoon E; Chiou C; Ghannoum M; Groll A H; Odds F C
New targets and delivery systems for antifungal therapy.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2000;38 Suppl 1():335-47.
2000: Graybill J R; Tollemar J; Torres-Rodríguez J M; Walsh T J; Roilides E; Farmaki E
Antifungal compounds: controversies, queries and conclusions.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2000;38 Suppl 1():323-33.
2000: Chiou C C; Groll A H; Walsh T J
New drugs and novel targets for treatment of invasive fungal infections in patients with cancer.
The oncologist 2000;5(2):120-35.
1999: Walsh T J; Groll A H
Emerging fungal pathogens: evolving challenges to immunocompromised patients for the twenty-first century.
Transplant infectious disease : an official journal of the Transplantation Society 1999;1(4):247-61.
1999: Rex J H; Walsh T J
Estimating the true cost of amphotericin B.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1999;29(6):1408-10.
1999: Groll A H; Walsh T J
MK-0991 (Merck & Co).
IDrugs : the investigational drugs journal 1999;2(11):1201-12.
1999: Groll A H; Mickiene D; Werner K; Piscitelli S C; Walsh T J
High-performance liquid chromatographic determination of liposomal nystatin in plasma and tissues for pharmacokinetic and tissue distribution studies.
Journal of chromatography. B, Biomedical sciences and applications 1999;735(1):51-62.
1999: Bekersky I; Boswell G W; Hiles R; Fielding R M; Buell D; Walsh T J
Safety and toxicokinetics of intravenous liposomal amphotericin B (AmBisome) in beagle dogs.
Pharmaceutical research 1999;16(11):1694-701.
1999: Groll A H; Petraitis V; Petraitiene R; Field-Ridley A; Calendario M; Bacher J; Piscitelli S C; Walsh T J
Safety and efficacy of multilamellar liposomal nystatin against disseminated candidiasis in persistently neutropenic rabbits.
Antimicrobial agents and chemotherapy 1999;43(10):2463-7.
1999: Müller F M; Kasai M; Francesconi A; Brillante B; Roden M; Peter J; Chanock S J; Walsh T J
Transmission of an azole-resistant isogenic strain of Candida albicans among human immunodeficiency virus-infected family members with oropharyngeal candidiasis.
Journal of clinical microbiology 1999;37(10):3405-8.
1999: Xu Y; Ambudkar I; Yamagishi H; Swaim W; Walsh T J; O'Connell B C
Histatin 3-mediated killing of Candida albicans: effect of extracellular salt concentration on binding and internalization.
Antimicrobial agents and chemotherapy 1999;43(9):2256-62.
1999: Lyman C A; Gonzalez C; Schneider M; Lee J; Walsh T J
Effects of the hematoregulatory peptide SK&F 107647 alone and in combination with amphotericin B against disseminated candidiasis in persistently neutropenic rabbits.
Antimicrobial agents and chemotherapy 1999;43(9):2165-9.
1999: Petraitiene R; Petraitis V; Groll A H; Candelario M; Sein T; Bell A; Lyman C A; McMillian C L; Bacher J; Walsh T J
Antifungal activity of LY303366, a novel echinocandin B, in experimental disseminated candidiasis in rabbits.
Antimicrobial agents and chemotherapy 1999;43(9):2148-55.
1999: Walsh T J; Seibel N L; Arndt C; Harris R E; Dinubile M J; Reboli A; Hiemenz J; Chanock S J
Amphotericin B lipid complex in pediatric patients with invasive fungal infections.
The Pediatric infectious disease journal 1999;18(8):702-8.
1999: Freifeld A; Marchigiani D; Walsh T; Chanock S; Lewis L; Hiemenz J; Hiemenz S; Hicks J E; Gill V; Steinberg S M; Pizzo P A
A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy.
The New England journal of medicine 1999;341(5):305-11.
1999: Roilides E; Tsaparidou S; Kadiltsoglou I; Sein T; Walsh T J
Interleukin-12 enhances antifungal activity of human mononuclear phagocytes against Aspergillus fumigatus: implications for a gamma interferon-independent pathway.
Infection and immunity 1999;67(6):3047-50.
1999: Callender D P; Jayaprakash N; Bell A; Petraitis V; Petraitiene R; Candelario M; Schaufele R; Dunn J M; Sei S; Walsh T J; Balis F M;
Pharmacokinetics of oral zidovudine entrapped in biodegradable nanospheres in rabbits.
Antimicrobial agents and chemotherapy 1999;43(4):972-4.
1999: Lyman C A; Garrett K F; Peter J; Gonzalez C; Walsh T J
Increased adherence of fluconazole-resistant isolates of Candida species to explanted esophageal mucosa.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1999;18(3):213-6.
1999: Müller F M; Groll A H; Walsh T J
Current approaches to diagnosis and treatment of fungal infections in children infected with human immuno deficiency virus.
European journal of pediatrics 1999;158(3):187-99.
1999: Walsh T J; Finberg R W; Arndt C; Hiemenz J; Schwartz C; Bodensteiner D; Pappas P; Seibel N; Greenberg R N; Dummer S; Schuster M; Holcenberg J S
Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group.
The New England journal of medicine 1999;340(10):764-71.
1999: De Lucca A J; Jacks T J; Takemoto J; Vinyard B; Peter J; Navarro E; Walsh T J
Fungal lethality, binding, and cytotoxicity of syringomycin-E.
Antimicrobial agents and chemotherapy 1999;43(2):371-3.
1999: Groll A H; Gonzalez C E; Giri N; Kligys K; Love W; Peter J; Feuerstein E; Bacher J; Piscitelli S C; Walsh T J
Liposomal nystatin against experimental pulmonary aspergillosis in persistently neutropenic rabbits: efficacy, safety and non-compartmental pharmacokinetics.
The Journal of antimicrobial chemotherapy 1999;43(1):95-103.
1999: De Lucca A J; Walsh T J
Antifungal peptides: novel therapeutic compounds against emerging pathogens.
Antimicrobial agents and chemotherapy 1999;43(1):1-11.
1999: Lyman C A; Navarro E; Garrett K F; Roberts D D; Pizzo P A; Walsh T J
Adherence of Candida albicans to bladder mucosa: development and application of a tissue explant assay.
Mycoses 1999;42(4):255-9.
1998: Foster C B; Lehrnbecher T; Mol F; Steinberg S M; Venzon D J; Walsh T J; Noack D; Rae J; Winkelstein J A; Curnutte J T; Chanock S J
Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous disease.
The Journal of clinical investigation 1998;102(12):2146-55.
1998: Roilides E; Dimitriadou-Georgiadou A; Sein T; Kadiltsoglou I; Walsh T J
Tumor necrosis factor alpha enhances antifungal activities of polymorphonuclear and mononuclear phagocytes against Aspergillus fumigatus.
Infection and immunity 1998;66(12):5999-6003.
1998: Roilides E; Anastasiou-Katsiardani A; Dimitriadou-Georgiadou A; Kadiltsoglou I; Tsaparidou S; Panteliadis C; Walsh T J
Suppressive effects of interleukin-10 on human mononuclear phagocyte function against Candida albicans and Staphylococcus aureus.
The Journal of infectious diseases 1998;178(6):1734-42.
1998: Petraitis V; Petraitiene R; Groll A H; Bell A; Callender D P; Sein T; Schaufele R L; McMillian C L; Bacher J; Walsh T J
Antifungal efficacy, safety, and single-dose pharmacokinetics of LY303366, a novel echinocandin B, in experimental pulmonary aspergillosis in persistently neutropenic rabbits.
Antimicrobial agents and chemotherapy 1998;42(11):2898-905.
1998: De Lucca A J; Bland J M; Jacks T J; Grimm C; Walsh T J
Fungicidal and binding properties of the natural peptides cecropin B and dermaseptin.
Medical mycology : official publication of the International Society for Human and Animal Mycology 1998;36(5):291-8.
1998: Groll A H; Sein T; Petraitis V; Petraitiene R; Callender D; Gonzalez C E; Giri N; Bacher J; Piscitelli S; Walsh T J
Compartmental pharmacokinetics and tissue drug distribution of the pradimicin derivative BMS 181184 in rabbits.
Antimicrobial agents and chemotherapy 1998;42(10):2700-5.
1998: Walsh T J
Primary cutaneous aspergillosis--an emerging infection among immunocompromised patients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1998;27(3):453-7.
1998: Gonzalez C E; Groll A H; Giri N; Shetty D; Al-Mohsen I; Sein T; Feuerstein E; Bacher J; Piscitelli S; Walsh T J
Antifungal activity of the pradimicin derivative BMS 181184 in the treatment of experimental pulmonary aspergillosis in persistently neutropenic rabbits.
Antimicrobial agents and chemotherapy 1998;42(9):2399-404.
1998: Walsh T J; Yeldandi V; McEvoy M; Gonzalez C; Chanock S; Freifeld A; Seibel N I; Whitcomb P O; Jarosinski P; Boswell G; Bekersky I; Alak A; Buell D; Barret J; Wilson W
Safety, tolerance, and pharmacokinetics of a small unilamellar liposomal formulation of amphotericin B (AmBisome) in neutropenic patients.
Antimicrobial agents and chemotherapy 1998;42(9):2391-8.
1998: Roilides E; Sein T; Schaufele R; Chanock S J; Walsh T J
Increased serum concentrations of interleukin-10 in patients with hepatosplenic candidiasis.
The Journal of infectious diseases 1998;178(2):589-92.
1998: Rodrigues R G; Yan S; Walsh T J; Roberts D D
Hemoglobin differentially induces binding of Candida, Trichosporon, and Saccharomyces species to fibronectin.
The Journal of infectious diseases 1998;178(2):497-502.
1998: Groll A H; Müller F M; Piscitelli S C; Walsh T J
Lipid formulations of amphotericin B: clinical perspectives for the management of invasive fungal infections in children with cancer.
Klinische Pädiatrie 1998;210(4):264-73.
1998: De Lucca A J; Bland J M; Grimm C; Jacks T J; Cary J W; Jaynes J M; Cleveland T E; Walsh T J
Fungicidal properties, sterol binding, and proteolytic resistance of the synthetic peptide D4E1.
Canadian journal of microbiology 1998;44(6):514-20.
1998: Walsh T J; Hiemenz J W; Seibel N L; Perfect J R; Horwith G; Lee L; Silber J L; DiNubile M J; Reboli A; Bow E; Lister J; Anaissie E J
Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1998;26(6):1383-96.
1998: Segal B H; Walsh T J; Liu J M; Wilson J D; Kwon-Chung K J
Invasive infection with Fusarium chlamydosporum in a patient with aplastic anemia.
Journal of clinical microbiology 1998;36(6):1772-6.
1998: Müller F M; Werner K E; Kasai M; Francesconi A; Chanock S J; Walsh T J
Rapid extraction of genomic DNA from medically important yeasts and filamentous fungi by high-speed cell disruption.
Journal of clinical microbiology 1998;36(6):1625-9.
1998: Roilides E; Katsifa H; Walsh T J
Pulmonary host defences against Aspergillus fumigatus.
Research in immunology 1998;149(4-5):454-65; discussion 523-4.
1998: Groll A H; De Lucca A J; Walsh T J
Emerging targets for the development of novel antifungal therapeutics.
Trends in microbiology 1998;6(3):117-24.
1998: Weng D E; Wilson W H; Little R; Walsh T J
Successful medical management of isolated renal zygomycosis: case report and review.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1998;26(3):601-5.
1998: Yan S; Rodrigues R G; Cahn-Hidalgo D; Walsh T J; Roberts D D
Hemoglobin induces binding of several extracellular matrix proteins to Candida albicans. Identification of a common receptor for fibronectin, fibrinogen, and laminin.
The Journal of biological chemistry 1998;273(10):5638-44.
1998: Odds F C; Van Gerven F; Espinel-Ingroff A; Bartlett M S; Ghannoum M A; Lancaster M V; Pfaller M A; Rex J H; Rinaldi M G; Walsh T J
Evaluation of possible correlations between antifungal susceptibilities of filamentous fungi in vitro and antifungal treatment outcomes in animal infection models.
Antimicrobial agents and chemotherapy 1998;42(2):282-8.
1998: Boswell G W; Bekersky I; Buell D; Hiles R; Walsh T J
Toxicological profile and pharmacokinetics of a unilamellar liposomal vesicle formulation of amphotericin B in rats.
Antimicrobial agents and chemotherapy 1998;42(2):263-8.
1998: Vázquez N; Walsh T J; Friedman D; Chanock S J; Lyman C A
Interleukin-15 augments superoxide production and microbicidal activity of human monocytes against Candida albicans.
Infection and immunity 1998;66(1):145-50.
1998: Walsh T J; Chanock S J
Diagnosis of invasive fungal infections: advances in nonculture systems.
Current clinical topics in infectious diseases 1998;18():101-53.
1998: Groll A H; Piscitelli S C; Walsh T J
Clinical pharmacology of systemic antifungal agents: a comprehensive review of agents in clinical use, current investigational compounds, and putative targets for antifungal drug development.
Advances in pharmacology (San Diego, Calif.) 1998;44():343-500.
1998: Rex J H; Walsh T J; Anaissie E J
Fungal infections in iatrogenically compromised hosts.
Advances in internal medicine 1998;43():321-71.
1997: Navarro E E; Almario J S; Schaufele R L; Bacher J; Walsh T J
Quantitative urine cultures do not reliably detect renal candidiasis in rabbits.
Journal of clinical microbiology 1997;35(12):3292-7.
1997: Roilides E; Kadiltsoglou I; Dimitriadou A; Hatzistilianou M; Manitsa A; Karpouzas J; Pizzo P A; Walsh T J
Interleukin-4 suppresses antifungal activity of human mononuclear phagocytes against Candida albicans in association with decreased uptake of blastoconidia.
FEMS immunology and medical microbiology 1997;19(2):169-80.
1997: Walsh T J; Whitcomb P; Piscitelli S; Figg W D; Hill S; Chanock S J; Jarosinski P; Gupta R; Pizzo P A
Safety, tolerance, and pharmacokinetics of amphotericin B lipid complex in children with hepatosplenic candidiasis.
Antimicrobial agents and chemotherapy 1997;41(9):1944-8.
1997: Edwards J E; Bodey G P; Bowden R A; Büchner T; de Pauw B E; Filler S G; Ghannoum M A; Glauser M; Herbrecht R; Kauffman C A; Kohno S; Martino P; Meunier F; Mori T; Pfaller M A; Rex J H; Rogers T R; Rubin R H; Solomkin J; Viscoli C; Walsh T J; White M
International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1997;25(1):43-59.
1997: Walsh T J; Kasai M; Francesconi A; Landsman D; Chanock S J
New evidence that Candida albicans possesses additional ATP-binding cassette MDR-like genes: implications for antifungal azole resistance.
Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology 1997;35(2):133-7.
1997: Rex J H; Pfaller M A; Galgiani J N; Bartlett M S; Espinel-Ingroff A; Ghannoum M A; Lancaster M; Odds F C; Rinaldi M G; Walsh T J; Barry A L
Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory Standards.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1997;24(2):235-47.
1997: Gonzalez C E; Couriel D R; Walsh T J
Disseminated zygomycosis in a neutropenic patient: successful treatment with amphotericin B lipid complex and granulocyte colony-stimulating factor.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1997;24(2):192-6.
1997: Shetty D; Giri N; Gonzalez C E; Pizzo P A; Walsh T J
Invasive aspergillosis in human immunodeficiency virus-infected children.
The Pediatric infectious disease journal 1997;16(2):216-21.
1997: DeLucca A J; Bland J M; Jacks T J; Grimm C; Cleveland T E; Walsh T J
Fungicidal activity of cecropin A.
Antimicrobial agents and chemotherapy 1997;41(2):481-3.
1997: Walsh T J; Giri N
Pradimicins: a novel class of broad-spectrum antifungal compounds.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1997;16(1):93-7.
1997: Roilides E; Dimitriadou A; Kadiltsoglou I; Sein T; Karpouzas J; Pizzo P A; Walsh T J
IL-10 exerts suppressive and enhancing effects on antifungal activity of mononuclear phagocytes against Aspergillus fumigatus.
Journal of immunology (Baltimore, Md. : 1950) 1997;158(1):322-9.
1997: Espinel-Ingroff A; Bartlett M; Bowden R; Chin N X; Cooper C; Fothergill A; McGinnis M R; Menezes P; Messer S A; Nelson P W; Odds F C; Pasarell L; Peter J; Pfaller M A; Rex J H; Rinaldi M G; Shankland G S; Walsh T J; Weitzman I
Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi.
Journal of clinical microbiology 1997;35(1):139-43.
1996: Chanock S J; Walsh T J
Evolving concepts of prevention and treatment of invasive fungal infections in pediatric bone marrow transplant recipients.
Bone marrow transplantation 1996;18 Suppl 3():S15-20.
1996: O'Connell B C; Xu T; Walsh T J; Sein T; Mastrangeli A; Crystal R G; Oppenheim F G; Baum B J
Transfer of a gene encoding the anticandidal protein histatin 3 to salivary glands.
Human gene therapy 1996;7(18):2255-61.
1996: Gonzalez C E; Venzon D; Lee S; Mueller B U; Pizzo P A; Walsh T J
Risk factors for fungemia in children infected with human immunodeficiency virus: a case-control study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1996;23(3):515-21.
1996: Gonzalez C E; Shetty D; Lewis L L; Mueller B U; Pizzo P A; Walsh T J
Cryptococcosis in human immunodeficiency virus-infected children.
The Pediatric infectious disease journal 1996;15(9):796-800.
1996: Yan S; Nègre E; Cashel J A; Guo N; Lyman C A; Walsh T J; Roberts D D
Specific induction of fibronectin binding activity by hemoglobin in Candida albicans grown in defined media.
Infection and immunity 1996;64(8):2930-5.
1996: Walsh T J; Hiemenz J W; Anaissie E
Recent progress and current problems in treatment of invasive fungal infections in neutropenic patients.
Infectious disease clinics of North America 1996;10(2):365-400.
1996: De Lucca A J; Walsh T J; Daigle D J
N-acetylcysteine inhibits germination of conidia and growth of Aspergillus spp. and Fusarium spp.
Antimicrobial agents and chemotherapy 1996;40(5):1274-6.
1996: Georgopapadakou N H; Walsh T J
Antifungal agents: chemotherapeutic targets and immunologic strategies.
Antimicrobial agents and chemotherapy 1996;40(2):279-91.
1996: Roilides E; Blake C; Holmes A; Pizzo P A; Walsh T J
Granulocyte-macrophage colony-stimulating factor and interferon-gamma prevent dexamethasone-induced immunosuppression of antifungal monocyte activity against Aspergillus fumigatus hyphae.
Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology 1996;34(1):63-9.
1996: Roilides E; Lyman C A; Mertins S D; Cole D J; Venzon D; Pizzo P A; Chanock S J; Walsh T J
Ex vivo effects of macrophage colony-stimulating factor on human monocyte activity against fungal and bacterial pathogens.
Cytokine 1996;8(1):42-8.
1996: Walsh T J; Gonzalez C; Lyman C A; Chanock S J; Pizzo P A
Invasive fungal infections in children: recent advances in diagnosis and treatment.
Advances in pediatric infectious diseases 1996;11():187-290.
1995: Walsh T J; Whitcomb P O; Revankar S G; Pizzo P A
Successful treatment of hepatosplenic candidiasis through repeated cycles of chemotherapy and neutropenia.
Cancer 1995;76(11):2357-62.
1995: Walsh T J; Francesconi A; Kasai M; Chanock S J
PCR and single-strand conformational polymorphism for recognition of medically important opportunistic fungi.
Journal of clinical microbiology 1995;33(12):3216-20.
1995: Roilides E; Sein T; Holmes A; Chanock S; Blake C; Pizzo P A; Walsh T J
Effects of macrophage colony-stimulating factor on antifungal activity of mononuclear phagocytes against Aspergillus fumigatus.
The Journal of infectious diseases 1995;172(4):1028-34.
1995: Berenguer J; Allende M C; Lee J W; Garrett K; Lyman C; Ali N M; Bacher J; Pizzo P A; Walsh T J
Pathogenesis of pulmonary aspergillosis. Granulocytopenia versus cyclosporine and methylprednisolone-induced immunosuppression.
American journal of respiratory and critical care medicine 1995;152(3):1079-86.
1995: Walsh T J; Merz W G; Lee J W; Schaufele R; Sein T; Whitcomb P O; Ruddel M; Burns W; Wingard J R; Switchenko A C
Diagnosis and therapeutic monitoring of invasive candidiasis by rapid enzymatic detection of serum D-arabinitol.
The American journal of medicine 1995;99(2):164-72.
1995: Walsh T J; Peter J; McGough D A; Fothergill A W; Rinaldi M G; Pizzo P A
Activities of amphotericin B and antifungal azoles alone and in combination against Pseudallescheria boydii.
Antimicrobial agents and chemotherapy 1995;39(6):1361-4.
1995: Walsh T J; Garrett K; Feurerstein E; Girton M; Allende M; Bacher J; Francesconi A; Schaufele R; Pizzo P A
Therapeutic monitoring of experimental invasive pulmonary aspergillosis by ultrafast computerized tomography, a novel, noninvasive method for measuring responses to antifungal therapy.
Antimicrobial agents and chemotherapy 1995;39(5):1065-9.
1995: Gehrt A; Peter J; Pizzo P A; Walsh T J
Effect of increasing inoculum sizes of pathogenic filamentous fungi on MICs of antifungal agents by broth microdilution method.
Journal of clinical microbiology 1995;33(5):1302-7.
1995: Walsh T J; Gonzalez C; Roilides E; Mueller B U; Ali N; Lewis L L; Whitcomb T O; Marshall D J; Pizzo P A
Fungemia in children infected with the human immunodeficiency virus: new epidemiologic patterns, emerging pathogens, and improved outcome with antifungal therapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1995;20(4):900-6.
1995: Roilides E; Holmes A; Blake C; Pizzo P A; Walsh T J
Effects of granulocyte colony-stimulating factor and interferon-gamma on antifungal activity of human polymorphonuclear neutrophils against pseudohyphae of different medically important Candida species.
Journal of leukocyte biology 1995;57(4):651-6.
1995: Freifeld A G; Walsh T; Marshall D; Gress J; Steinberg S M; Hathorn J; Rubin M; Jarosinski P; Gill V; Young R C
Monotherapy for fever and neutropenia in cancer patients: a randomized comparison of ceftazidime versus imipenem.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(1):165-76.
1995: Lyman C A; Devi S J; Nathanson J; Frasch C E; Pizzo P A; Walsh T J
Detection and quantitation of the glucuronoxylomannan-like polysaccharide antigen from clinical and nonclinical isolates of Trichosporon beigelii and implications for pathogenicity.
Journal of clinical microbiology 1995;33(1):126-30.
1995: Walsh T J; Lyman C A
New antifungal compounds and strategies for treatment of invasive fungal infections in patients with neoplastic diseases.
Cancer treatment and research 1995;79():113-48.
1994: Lyman C A; Garrett K F; Pizzo P A; Walsh T J
Response of human polymorphonuclear leukocytes and monocytes to Trichosporon beigelii: host defense against an emerging opportunistic pathogen.
The Journal of infectious diseases 1994;170(6):1557-65.
1994: Navarro E E; Almario J S; King C; Bacher J; Pizzo P A; Walsh T J
Detection of Candida casts in experimental renal candidiasis: implications for the diagnosis and pathogenesis of upper urinary tract infection.
Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology 1994;32(6):415-26.
1994: Roilides E; Robinson T; Sein T; Pizzo P A; Walsh T J
In vitro and ex vivo effects of cyclosporin A on phagocytic host defenses against Aspergillus fumigatus.
Antimicrobial agents and chemotherapy 1994;38(12):2883-8.
1994: Roilides E; Holmes A; Blake C; Venzon D; Pizzo P A; Walsh T J
Antifungal activity of elutriated human monocytes against Aspergillus fumigatus hyphae: enhancement by granulocyte-macrophage colony-stimulating factor and interferon-gamma.
The Journal of infectious diseases 1994;170(4):894-9.
1994: Nègre E; Vogel T; Levanon A; Guy R; Walsh T J; Roberts D D
The collagen binding domain of fibronectin contains a high affinity binding site for Candida albicans.
The Journal of biological chemistry 1994;269(35):22039-45.
1994: Walsh T J; Renshaw G; Andrews J; Kwon-Chung J; Cunnion R C; Pass H I; Taubenberger J; Wilson W; Pizzo P A
Invasive zygomycosis due to Conidiobolus incongruus.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1994;19(3):423-30.
1994: Berenguer J; Ali N M; Allende M C; Lee J; Garrett K; Battaglia S; Piscitelli S C; Rinaldi M G; Pizzo P A; Walsh T J
Itraconazole for experimental pulmonary aspergillosis: comparison with amphotericin B, interaction with cyclosporin A, and correlation between therapeutic response and itraconazole concentrations in plasma.
Antimicrobial agents and chemotherapy 1994;38(6):1303-8.
1994: Walsh T J; Hiemenz J; Pizzo P A
Evolving risk factors for invasive fungal infections--all neutropenic patients are not the same.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1994;18(5):793-8.
1994: Georgopapadakou N H; Walsh T J
Human mycoses: drugs and targets for emerging pathogens.
Science (New York, N.Y.) 1994;264(5157):371-3.
1994: Lyman C A; Walsh T J
Phagocytosis of medically important yeasts by polymorphonuclear leukocytes.
Infection and immunity 1994;62(4):1489-93.
1994: Lee J W; Amantea M A; Francis P A; Navarro E E; Bacher J; Pizzo P A; Walsh T J
Pharmacokinetics and safety of a unilamellar liposomal formulation of amphotericin B (AmBisome) in rabbits.
Antimicrobial agents and chemotherapy 1994;38(4):713-8.
1994: Allende M C; Lee J W; Francis P; Garrett K; Dollenberg H; Berenguer J; Lyman C A; Pizzo P A; Walsh T J
Dose-dependent antifungal activity and nephrotoxicity of amphotericin B colloidal dispersion in experimental pulmonary aspergillosis.
Antimicrobial agents and chemotherapy 1994;38(3):518-22.
1994: Francis P; Lee J W; Hoffman A; Peter J; Francesconi A; Bacher J; Shelhamer J; Pizzo P A; Walsh T J
Efficacy of unilamellar liposomal amphotericin B in treatment of pulmonary aspergillosis in persistently granulocytopenic rabbits: the potential role of bronchoalveolar D-mannitol and serum galactomannan as markers of infection.
The Journal of infectious diseases 1994;169(2):356-68.
1994: Switchenko A C; Miyada C G; Goodman T C; Walsh T J; Wong B; Becker M J; Ullman E F
An automated enzymatic method for measurement of D-arabinitol, a metabolite of pathogenic Candida species.
Journal of clinical microbiology 1994;32(1):92-7.
1994: Walsh T J; Kelly P; Peebles R; Lee J; Lecciones J; Pizzo P A
Biochemical and pharmacological factors causing induction and suppression of germination of Trichosporon beigelii.
Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology 1994;32(2):123-32.
1994: Walsh T J; Lee J W; Sien T; Schaufele R; Bacher J; Switchenko A C; Goodman T C; Pizzo P A
Serum D-arabinitol measured by automated quantitative enzymatic assay for detection and therapeutic monitoring of experimental disseminated candidiasis: correlation with tissue concentrations of Candida albicans.
Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology 1994;32(3):205-15.
1994: Walsh T J; De Pauw B; Anaissie E; Martino P
Recent advances in the epidemiology, prevention and treatment of invasive fungal infections in neutropenic patients.
Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology 1994;32 Suppl 1():33-51.
1993: Marcus S G; Walsh T J; Pizzo P A; Danforth D N
Hepatic abscess in cancer patients. Characterization and management.
Archives of surgery (Chicago, Ill. : 1960) 1993;128(12):1358-64; discussion 1364.
1993: Roilides E; Holmes A; Blake C; Pizzo P A; Walsh T J
Defective antifungal activity of monocyte-derived macrophages from human immunodeficiency virus-infected children against Aspergillus fumigatus.
The Journal of infectious diseases 1993;168(6):1562-5.
1993: Walsh T J; Lee J W
Prevention of invasive fungal infections in patients with neoplastic disease.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1993;17 Suppl 2():S468-80.
1993: Roilides E; Uhlig K; Venzon D; Pizzo P A; Walsh T J
Prevention of corticosteroid-induced suppression of human polymorphonuclear leukocyte-induced damage of Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon.
Infection and immunity 1993;61(11):4870-7.
1993: Walsh T J
Management of immunocompromised patients with evidence of an invasive mycosis.
Hematology/oncology clinics of North America 1993;7(5):1003-26.
1993: Standiford H C; Walsh T J; Drusano G L; Tatem B A; Townsend R J
Serum inhibitory and bactericidal activity against methicillin-resistant Staphylococcus aureus in volunteers receiving novobiocin and rifampin alone and in combination.
Diagnostic microbiology and infectious disease 1993;17(2):135-42.
1993: Berenguer J; Buck M; Witebsky F; Stock F; Pizzo P A; Walsh T J
Lysis-centrifugation blood cultures in the detection of tissue-proven invasive candidiasis. Disseminated versus single-organ infection.
Diagnostic microbiology and infectious disease 1993;17(2):103-9.
1993: Walsh T J; Standiford H C; Reboli A C; John J F; Mulligan M E; Ribner B S; Montgomerie J Z; Goetz M B; Mayhall C G; Rimland D
Randomized double-blinded trial of rifampin with either novobiocin or trimethoprim-sulfamethoxazole against methicillin-resistant Staphylococcus aureus colonization: prevention of antimicrobial resistance and effect of host factors on outcome.
Antimicrobial agents and chemotherapy 1993;37(6):1334-42.
1993: Roilides E; Holmes A; Blake C; Pizzo P A; Walsh T J
Impairment of neutrophil antifungal activity against hyphae of Aspergillus fumigatus in children infected with human immunodeficiency virus.
The Journal of infectious diseases 1993;167(4):905-11.
1993: Roilides E; Uhlig K; Venzon D; Pizzo P A; Walsh T J
Enhancement of oxidative response and damage caused by human neutrophils to Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon.
Infection and immunity 1993;61(4):1185-93.
1993: Allende M; Pizzo P A; Horowitz M; Pass H I; Walsh T J
Pulmonary cryptococcosis presenting as metastases in children with sarcomas.
The Pediatric infectious disease journal 1993;12(3):240-3.
1993: Walsh T J; Melcher G P; Lee J W; Pizzo P A
Infections due to Trichosporon species: new concepts in mycology, pathogenesis, diagnosis and treatment.
Current topics in medical mycology 1993;5():79-113.
1992: Francis P; Walsh T J
Evolving role of flucytosine in immunocompromised patients: new insights into safety, pharmacokinetics, and antifungal therapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1992;15(6):1003-18.
1992: Pfaller M A; Dupont B; Kobayashi G S; Müller J; Rinaldi M G; Espinel-Ingroff A; Shadomy S; Troke P F; Walsh T J; Warnock D W
Standardized susceptibility testing of fluconazole: an international collaborative study.
Antimicrobial agents and chemotherapy 1992;36(9):1805-9.
1992: Roilides E; Uhlig K; Venzon D; Pizzo P A; Walsh T J
Neutrophil oxidative burst in response to blastoconidia and pseudohyphae of Candida albicans: augmentation by granulocyte colony-stimulating factor and interferon-gamma.
The Journal of infectious diseases 1992;166(3):668-73.
1992: Walsh T J; Lee J W; Roilides E; Pizzo P A
Recent progress and current problems in management of invasive fungal infections in patients with neoplastic diseases.
Current opinion in oncology 1992;4(4):647-55.
1992: Walsh T J; Lee J W; Melcher G P; Navarro E; Bacher J; Callender D; Reed K D; Wu T; Lopez-Berestein G; Pizzo P A
Experimental Trichosporon infection in persistently granulocytopenic rabbits: implications for pathogenesis, diagnosis, and treatment of an emerging opportunistic mycosis.
The Journal of infectious diseases 1992;166(1):121-33.
1992: Lyman C A; Walsh T J
Systemically administered antifungal agents. A review of their clinical pharmacology and therapeutic applications.
Drugs 1992;44(1):9-35.
1992: Lee J W; Seibel N L; Amantea M; Whitcomb P; Pizzo P A; Walsh T J
Safety and pharmacokinetics of fluconazole in children with neoplastic diseases.
The Journal of pediatrics 1992;120(6):987-93.
1992: Walsh T J; Lee J W; Bacher J; Kelly P; Pizzo P A
Continuous intravenous infusion and simultaneous pharmacokinetic monitoring in ambulatory rabbits with a programmable micropump and dual subcutaneous Silastic central venous catheters.
Laboratory animal science 1992;42(3):286-92.
1992: Francis P; Walsh T J
Approaches to management of fungal infections in cancer patients.
Oncology (Williston Park, N.Y.) 1992;6(5):133-44; discussion 144, 147-8.
1992: Walsh T J; Pizzo P A
Experimental gastrointestinal and disseminated candidiasis in immunocompromised animals.
European journal of epidemiology 1992;8(3):477-83.
1992: Lecciones J A; Lee J W; Navarro E E; Witebsky F G; Marshall D; Steinberg S M; Pizzo P A; Walsh T J
Vascular catheter-associated fungemia in patients with cancer: analysis of 155 episodes.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1992;14(4):875-83.
1992: Francis P; Walsh T J
Current approaches to the management of fungal infections in cancer patients: Part 1.
Oncology (Williston Park, N.Y.) 1992;6(4):81-92; discussion 97-100.
1992: Walsh T J; Lee J W; Roilides E; Francis P; Bacher J; Lyman C A; Pizzo P A
Experimental antifungal chemotherapy in granulocytopenic animal models of disseminated candidiasis: approaches to understanding investigational antifungal compounds for patients with neoplastic diseases.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1992;14 Suppl 1():S139-47.
1992: Odds F C; Arai T; Disalvo A F; Evans E G; Hay R J; Randhawa H S; Rinaldi M G; Walsh T J
Nomenclature of fungal diseases: a report and recommendations from a Sub-Committee of the International Society for Human and Animal Mycology (ISHAM).
Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology 1992;30(1):1-10.
1992: Dixon D M; Walsh T J
Human pathogenesis.
Biotechnology (Reading, Mass.) 1992;23():249-67.
1992: Walsh T J; Van Cutsem J; Polak A M; Graybill J R
Immunomodulation and antifungal therapy of experimental invasive candidosis, histoplasmosis and aspergillosis: recent advances and concepts.
Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology 1992;30 Suppl 1():225-40.
1991: Pizzo P A; Rubin M; Freifeld A; Walsh T J
The child with cancer and infection. II. Nonbacterial infections.
The Journal of pediatrics 1991;119(6):845-57.
1991: Pizzo P A; Rubin M; Freifeld A; Walsh T J
The child with cancer and infection. I. Empiric therapy for fever and neutropenia, and preventive strategies.
The Journal of pediatrics 1991;119(5):679-94.
1991: Walsh T J; Lee J W; Kelly P; Bacher J; Lecciones J; Thomas V; Lyman C; Coleman D; Gordee R; Pizzo P A
Antifungal effects of the nonlinear pharmacokinetics of cilofungin, a 1,3-beta-glucan synthetase inhibitor, during continuous and intermittent intravenous infusions in treatment of experimental disseminated candidiasis.
Antimicrobial agents and chemotherapy 1991;35(7):1321-8.
1991: Johnston P G; Lee J; Domanski M; Dressler F; Tucker E; Rothenberg M; Cunnion R E; Pizzo P A; Walsh T J
Late recurrent Candida endocarditis.
Chest 1991;99(6):1531-3.
1991: Lee J W; Ritter W; Lecciones J; Kelly P; Pizzo P A; Walsh T J
Plasma pharmacokinetics and tissue penetration of a novel antifungal triazole, Bay R 3783, and its long-lasting active metabolite, Bay U 3625, in rabbits.
The Journal of antimicrobial chemotherapy 1991;27(6):837-44.
1991: Walsh T J; Lee J; Lecciones J; Rubin M; Butler K; Francis P; Weinberger M; Roilides E; Marshall D; Gress J
Empiric therapy with amphotericin B in febrile granulocytopenic patients.
Reviews of infectious diseases 1991;13(3):496-503.
1991: Walsh T J; Rubin M; Hathorn J; Gress J; Thaler M; Skelton J; McKnight J; Browne M; Marshall D; Cotton D
Amphotericin B vs high-dose ketoconazole for empirical antifungal therapy among febrile, granulocytopenic cancer patients. A prospective, randomized study.
Archives of internal medicine 1991;151(4):765-70.
1991: Walsh T J; Hathorn J W; Sobel J D; Merz W G; Sanchez V; Maret S M; Buckley H R; Pfaller M A; Schaufele R; Sliva C
Detection of circulating candida enolase by immunoassay in patients with cancer and invasive candidiasis.
The New England journal of medicine 1991;324(15):1026-31.
1991: Levine S J; Walsh T J; Martinez A; Eichacker P Q; Lopez-Berestein G; Natanson C
Cardiopulmonary toxicity after liposomal amphotericin B infusion.
Annals of internal medicine 1991;114(8):664-6.
1991: Roilides E; Walsh T J; Pizzo P A; Rubin M
Granulocyte colony-stimulating factor enhances the phagocytic and bactericidal activity of normal and defective human neutrophils.
The Journal of infectious diseases 1991;163(3):579-83.
1990: Lee J W; Melcher G A; Rinaldi M G; Pizzo P A; Walsh T J
Patterns of morphologic variation among isolates of Trichosporon beigelii.
Journal of clinical microbiology 1990;28(12):2823-7.
1990: Lee J W; Kelly P; Lecciones J; Coleman D; Gordee R; Pizzo P A; Walsh T J
Cilofungin (LY121019) shows nonlinear plasma pharmacokinetics and tissue penetration in rabbits.
Antimicrobial agents and chemotherapy 1990;34(11):2240-5.
1990: Stevenson H; Gazdar A F; Phelps R; Linnoila R I; Ihde D C; Ghosh B; Walsh T; Woods E L; Oie H; O'Connor T
Tumor cell lines established in vitro: an independent prognostic factor for survival in non-small-cell lung cancer.
Annals of internal medicine 1990;113(10):764-70.
1990: Roilides E; Mertins S; Eddy J; Walsh T J; Pizzo P A; Rubin M
Impairment of neutrophil chemotactic and bactericidal function in children infected with human immunodeficiency virus type 1 and partial reversal after in vitro exposure to granulocyte-macrophage colony-stimulating factor.
The Journal of pediatrics 1990;117(4):531-40.
1990: Walsh T J; Lee J W; Lecciones J; Kelly P; Peter J; Thomas V; Bacher J; Pizzo P A
SCH-39304 in prevention and treatment of disseminated candidiasis in persistently granulocytopenic rabbits.
Antimicrobial agents and chemotherapy 1990;34(8):1560-4.
1990: Walsh T J; Melcher G P; Rinaldi M G; Lecciones J; McGough D A; Kelly P; Lee J; Callender D; Rubin M; Pizzo P A
Trichosporon beigelii, an emerging pathogen resistant to amphotericin B.
Journal of clinical microbiology 1990;28(7):1616-22.
1990: Walsh T J; Lester-McCully C; Rinaldi M G; Wallace J E; Balis F M; Lee J W; Pizzo P A; Poplack D G
Penetration of SCH-39304, a new antifungal triazole, into cerebrospinal fluid of primates.
Antimicrobial agents and chemotherapy 1990;34(6):1281-4.
1990: Walsh T J
Invasive pulmonary aspergillosis in patients with neoplastic diseases.
Seminars in respiratory infections 1990;5(2):111-22.
1990: Pizzo P A; Walsh T J
Fungal infections in the pediatric cancer patient.
Seminars in oncology 1990;17(3 Suppl 6):6-9.
1990: Whelan W L; Delga J M; Wadsworth E; Walsh T J; Kwon-Chung K J; Calderone R; Lipke P N
Isolation and characterization of cell surface mutants of Candida albicans.
Infection and immunity 1990;58(6):1552-7.
1990: Walsh T J; Aoki S; Mechinaud F; Bacher J; Lee J; Rubin M; Pizzo P A
Effects of preventive, early, and late antifungal chemotherapy with fluconazole in different granulocytopenic models of experimental disseminated candidiasis.
The Journal of infectious diseases 1990;161(4):755-60.
1990: Walsh T J; Lee J; Aoki S; Mechinaud F; Bacher J; Lecciones J; Thomas V; Rubin M; Pizzo P A
Experimental basis for use of fluconazole for preventive or early treatment of disseminated candidiasis in granulocytopenic hosts.
Reviews of infectious diseases 1990;12 Suppl 3():S307-17.
1990: Roilides E; Walsh T J; Rubin M; Venzon D; Pizzo P A
Effects of antifungal agents on the function of human neutrophils in vitro.
Antimicrobial agents and chemotherapy 1990;34(2):196-201.
1990: Walsh T J; Jarosinski P F; Fromtling R A
Increasing usage of systemic antifungal agents.
Diagnostic microbiology and infectious disease 1990;13(1):37-40.
1990: Walsh T J
Role of surveillance cultures in prevention and treatment of fungal infections.
NCI monographs : a publication of the National Cancer Institute 1990;(9):43-5.
1990: Rubin M; Walsh T; Butler K; Lee J; Lecciones J; Weinberger M; Roilides E; Gress J; Marshall D; Pizzo P A
The febrile neutropenic patient: newer options for empirical therapy.
Haematology and blood transfusion 1990;33():531-8.
1989: Lee J W; Lin C; Loebenberg D; Rubin M; Pizzo P A; Walsh T J
Pharmacokinetics and tissue penetration of Sch 39304 in granulocytopenic and nongranulocytopenic rabbits.
Antimicrobial agents and chemotherapy 1989;33(11):1932-5.
1989: Dixon D M; Walsh T J; Merz W G; McGinnis M R
Infections due to Xylohypha bantiana (Cladosporium trichoides).
Reviews of infectious diseases 1989;11(4):515-25.
1989: Walsh T J; Dixon D M
Nosocomial aspergillosis: environmental microbiology, hospital epidemiology, diagnosis and treatment.
European journal of epidemiology 1989;5(2):131-42.
1989: Adamson P C; Rinaldi M G; Pizzo P A; Walsh T J
Amphotericin B in the treatment of Candida cholecystitis.
The Pediatric infectious disease journal 1989;8(6):408-11.
1989: Walsh T J; Salkin I F; Dixon D M; Hurd N J
Clinical, microbiological, and experimental animal studies of Candida lipolytica.
Journal of clinical microbiology 1989;27(5):927-31.
1989: Dixon D M; Polak A; Walsh T J
Fungus dose-dependent primary pulmonary aspergillosis in immunosuppressed mice.
Infection and immunity 1989;57(5):1452-6.
1989: Walsh T J; Foulds G; Pizzo P A
Pharmacokinetics and tissue penetration of fluconazole in rabbits.
Antimicrobial agents and chemotherapy 1989;33(4):467-9.
1989: Walsh T J
Trichosporonosis.
Infectious disease clinics of North America 1989;3(1):43-52.
1988: Walsh T J; Bacher J; Pizzo P A
Chronic silastic central venous catheterization for induction, maintenance and support of persistent granulocytopenia in rabbits.
Laboratory animal science 1988;38(4):467-71.
1988: Walsh T J; Hamilton S R; Belitsos N
Esophageal candidiasis. Managing an increasingly prevalent infection.
Postgraduate medicine 1988;84(2):193-6, 201-5.
1988: Walsh T J; Pizzo A
Treatment of systemic fungal infections: recent progress and current problems.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1988;7(4):460-75.
1988: Howard J R; Veach S R; DeVaney K; Walsh T; Cotelingam J D; Johnson B E
The development of small cell lung cancer in the contralateral lung of a patient surviving 8 years after the original diagnosis of small cell lung cancer.
Cancer 1988;62(2):436-9.
1988: Walsh T J
The febrile granulocytopenic patient in the intensive care unit.
Critical care clinics 1988;4(2):259-80.
1988: Arndt C A; Walsh T J; McCully C L; Balis F M; Pizzo P A; Poplack D G
Fluconazole penetration into cerebrospinal fluid: implications for treating fungal infections of the central nervous system.
The Journal of infectious diseases 1988;157(1):178-80.
1988: Walsh T J; Pizzo P A
Nosocomial fungal infections: a classification for hospital-acquired fungal infections and mycoses arising from endogenous flora or reactivation.
Annual review of microbiology 1988;42():517-45.
1987: Walsh T J
Recent advances in the treatment of systemic fungal infections.
Methods and findings in experimental and clinical pharmacology 1987;9(11):769-78.
1987: Walsh T J; Dixon D M; Polak A; Salkin I F
Comparative histopathology of Dactylaria constricta, Fonsecaea pedrosoi, Wangiella dermatitidis, and Xylohypha bantiana in experimental phaeohyphomycosis of the central nervous system.
Mykosen 1987;30(5):215-25.
1987: Walsh T J; McEntee C; Dixon D M
Tissue homogenization with sterile reinforced polyethylene bags for quantitative culture of Candida albicans.
Journal of clinical microbiology 1987;25(5):931-2.
1987: Dixon D M; Walsh T J; Salkin I F; Polak A
Dactylaria constricta: another dematiaceous fungus with neurotropic potential in mammals.
Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology 1987;25(1):55-8.
1986: Mullen P; Jude C; Borkon M; Porterfield J; Walsh T J
Aspergillus mural endocarditis. Clinical and echocardiographic diagnosis.
Chest 1986;90(3):451-2.
1986: Walsh T J; Merz W G
Pathologic features in the human alimentary tract associated with invasiveness of Candida tropicalis.
American journal of clinical pathology 1986;85(4):498-502.
1986: Walsh T J; Auger F; Tatem B A; Hansen S L; Standiford H C
Novobiocin and rifampicin in combination against methicillin-resistant Staphylococcus aureus: an in-vitro comparison with vancomycin plus rifampicin.
The Journal of antimicrobial chemotherapy 1986;17(1):75-82.
1986: Walsh T J; Bustamente C I; Vlahov D; Standiford H C
Candidal suppurative peripheral thrombophlebitis: recognition, prevention, and management.
Infection control : IC 1986;7(1):16-22.
1985: Walsh T J; Hier D B; Caplan L R
Fungal infections of the central nervous system: comparative analysis of risk factors and clinical signs in 57 patients.
Neurology 1985;35(11):1654-7.
1985: Walsh T J; Hier D B; Caplan L R
Aspergillosis of the central nervous system: clinicopathological analysis of 17 patients.
Annals of neurology 1985;18(5):574-82.
1985: Walsh T J; Venanzi W E; Dixon D M
Quantification of medically important Candida species and Torulopsis glabrata by a spiral inoculation system: correlation with pour plate and spread plate methods.
Journal of clinical microbiology 1985;22(5):745-7.
1985: Walsh T J; Hansen S L; Tatem B A; Auger F; Standiford H C
Activity of novobiocin against methicillin-resistant Staphylococcus aureus.
The Journal of antimicrobial chemotherapy 1985;15(4):435-40.
1980: Walsh T J; Hutchins G M
Postoperative Candida infections of the heart in children: clinicopathologic study of a continuing problem of diagnosis and therapy.
Journal of pediatric surgery 1980;15(3):325-31.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

THOMAS WALSH

Research Profile (preview)

Chemicals & Drugs

Disorders

Living Beings

Procedures

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of THOMAS WALSH (preview)

All Publications